PMH12 Medication Adherence, Diabetic Care and Risk of Acute Complications of Type II Diabetics with Schizophrenia Receiving Oral Hypoglycemic Therapy (Englisch)
- Neue Suche nach: Cheng, J. S.
- Neue Suche nach: Shih, Y. T.
- Neue Suche nach: Cheng, J. S.
- Neue Suche nach: Shih, Y. T.
In:
VALUE IN HEALTH
;
15
, 7
;
A670-A671
;
2012
-
ISSN:
- Aufsatz (Zeitschrift) / Print
-
Titel:PMH12 Medication Adherence, Diabetic Care and Risk of Acute Complications of Type II Diabetics with Schizophrenia Receiving Oral Hypoglycemic Therapy
-
Beteiligte:Cheng, J. S. ( Autor:in ) / Shih, Y. T. ( Autor:in )
-
Erschienen in:VALUE IN HEALTH ; 15, 7 ; A670-A671
-
Verlag:
- Neue Suche nach: Blackwell Publishing Ltd
-
Erscheinungsdatum:01.01.2012
-
Format / Umfang:A670-A671
-
ISSN:
-
Medientyp:Aufsatz (Zeitschrift)
-
Format:Print
-
Sprache:Englisch
- Neue Suche nach: 610
- Weitere Informationen zu Dewey Decimal Classification
-
Klassifikation:
DDC: 610 -
Datenquelle:
© Metadata Copyright the British Library Board and other contributors. All rights reserved.
Inhaltsverzeichnis – Band 15, Ausgabe 7
Zeige alle Jahrgänge und Ausgaben
Die Inhaltsverzeichnisse werden automatisch erzeugt und basieren auf den im Index des TIB-Portals verfügbaren Einzelnachweisen der enthaltenen Beiträge. Die Anzeige der Inhaltsverzeichnisse kann daher unvollständig oder lückenhaft sein.
- A278
-
PR2 Guiding Principles for Providing Effective Access to Medicines in Emerging MarketsShankar, R. / Hickson, S. et al. | 2012
- A282
-
MO2 Impact of Structural Assumptions on Cost-Effectiveness Outcomes: Towards a Standardized Cost-Effectiveness Model for Adjuvant Breast Cancer TherapiesFrederix, G. W. / Van hasselt, J. G. / Schellens, J. H. / Hö / vels, A. M. / Huitema, A. D. / Raaijmakers, J. A. / Severens, J. et al. | 2012
- A283
-
PA3 Limited Access to Cataract Surgery in PolandSzmurlo, D. / Fundament, T. / Kopec, G. / Brzyski, D. / Wladysiuk, M. / Landa, K. et al. | 2012
- A285
-
CL2 Statistical Considerations in Estimating Survival for Economic Evaluations in OncologyKhan, N. / Shah, D. / Briggs, A. / Park, J. / Huang, H. / Hawkins, N. et al. | 2012
- A286
-
DU3 Market Access Delays for CNS Drugs in EuropeFlostrand, S. J. / Anderson, L. / Esposito, G. et al. | 2012
- A287
-
RE4 Beyond the Evidence - The Influence of Decision Processes on Outcomes in Coverage Determination of Health TechnologiesFischer, K. E. / Rogowski, W. H. / Leidl, R. / Stollenwerk, B. et al. | 2012
- A288
-
PHP1 Incorporating the Patient's Voice Into the Assessment of Medical Devices: A Comparison of the United States and EuropeDoward, L. / Whalley, D. / Houghton, K. / DeMuro, C. / Evans, E. / Gnanasakthy, A. et al. | 2012
- A289
-
PHP7 How Do Reimbursement Systems Encourage or Inhibit Adoption of Innovative Medical Devices in an Ambulatory Setting?Wilkinson, G. / Drummond, M. et al. | 2012
- A290
-
PHP12 Patented Drug Extension Strategies on Health Care Spending: A Cost-Evaluation AnalysisVernaz, N. / Haller, G. / Girardin, F. / Huttner, B. / Dayer, P. / Muscionico, D. / Salomon, J. L. / Bonnabry, P. et al. | 2012
- A291
-
PHP18 The Effect of Law for Economical Use of Medications 2006 on the Catchment Population of Community Pharmacies Between 2007-2010Boncz, I. / Donka-Verebes, x. / Oberfrank, F. et al. | 2012
- A292
-
PHP23 The Early Benefit Assessment of New Pharmaceuticals in Germany (“AMNOG”): A Structured Survey Analysis One Year After EnactmentStoeckel, F. / Neubauer, A. S. et al. | 2012
- A294
-
PHP34 France Market Access: Review of 2011-2012 Assessments by Transparency CommitteeAggarwal, S. et al. | 2012
- A295
-
PHP39 Explaning Differences in EU5 Market Penetration Levels and Rates of Biosimilars: The Case of Epoetine, Granulocyte-Colony Stimulating Factor, and Growth HormonesFrenzel, A. / Schmidt, N. / Grahl, J. et al. | 2012
- A297
-
PHP51 Perception of Parallel Trade of Pharmaceuticals in Poland – Results of National Market ResearchBaran-Lewandowska, I. / Hermanowski, T. et al. | 2012
- A298
-
PHP57 Emerging Drug Reimbursement Models: Lessons and Implications from Cancer Drug Access SchemesAggarwal, S. et al. | 2012
- A299
-
PHP63 Potential Effects of Changes in Pricing Regulations Between 2004 and 2011 on the Turkish Pharmaceutical IndustryMemis, S. A. / Deger, C. / Marmarali, B. / Parali, E. / Sumer, F. / Karakeben, K. / Kayadibinli, M. / Cetinelli, S. T. et al. | 2012
- A300
-
PHP68 The Effect of Resetting the Clock in Health CareGresz, M. / Varga, S. / Sebestyé / n, A. / Toldi, J. / Bogá / r, L. / Molics, B. / Boncz, I. et al. | 2012
- A301
-
PHP74 Cost-of-Illness of Patient-Reported Adverse Drug Events – a Population-Based SurveyGyllensten, H. / Rehnberg, C. / Jö / nsson, A. K. / Petzold, M. / Carlsten, A. / Andersson Sundell, K. et al. | 2012
- A303
-
PHP86 Cost-Effectiveness in Health Care Programs: A Literature ReviewVanhaute, O. A. / Annemans, L. et al. | 2012
- A304
-
PHP91 Is There an Overuse of Computed Tomography (CT) Scanning of Patients in United States Hospitals? A Review of the EvidenceWang, Z. / Boswell, E. / Kokkotos, F. K. / Dong, X. / Liu, Y. / Tong, H. / Xiao, H. et al. | 2012
- A305
-
PHP97 The Regional Distribution of Disabled Pensioners of HungaryTurcsanyi, K. / Pakai, A. / Szabó / J. / Olá / h, A. / Gombos, G. / Gresz, M. / Molics, B. / Boncz, I. et al. | 2012
- A306
-
PHP102 Patient Satisfaction with Pharmacies ConditionRasekh, H. / Rangchian, M. / Mehralian, G. / Bagherian, S. J. et al. | 2012
- A307
-
PHP107 Experts' Views on the Introduction of a Monopsony in Health Care Services in GreeceSkroumpelos, A. / Zavras, D. / Pavi, E. / Kyriopoulos, J. et al. | 2012
- A309
-
PHP118 Estimating the Probability of a Recommendation for Reimbursement for a New Drug in the UK Using an MCDA ApproachWilliams, P. / Mauskopf, J. A. / Kilburg, A. / Lebiecki, J. et al. | 2012
- A310
-
PHP124 Comparison of HTA Dossier Requirements Across EuropeCasamayor, M. / Van Engen, A. et al. | 2012
- A311
-
PHP130 Guidelines Without Guidance: The Case of Epidemiological Data Beyond Clinical TrialsSandmann, F. G. / Herrmann, K. H. / Zhou, M. / Gerber, A. / Lhachimi, S. K. et al. | 2012
- A312
-
PHP135 Stakeholders's Views of the Social Insurance Reform in GreeceMylona, K. / Skroumpelos, A. / Tsiantou, V. / Karampli, E. / Pavi, E. / Kyriopoulos, J. et al. | 2012
- A313
-
PHP141 Effects of Changing Health Policy on Pharmacoeconomics and Health Outcome Studies in TurkeyKockaya, G. / Daylan Kockaya, P. / Ergin Oguzhan, G. et al. | 2012
- A314
-
PHP146 Pharmacoeconomic Education for Pharmacy Students in the Russian FederationMakhinova, T. / Makhinova, E. N. / Rascati, K. L. et al. | 2012
- A315
-
PHP152 The Early Benefit Assessment of Drugs That are Launched Before 2011Weber, B. et al. | 2012
- A316
-
PHP157 To What Extent Does the Federal Joint Committee Follows the Evidence Based Recommendations by IQWiGWeber, B. / Schmitter, S. / Schiffner-Rohe, J. et al. | 2012
- A317
-
PHP162 Review of NICE's Technology Appraisal RecommendationsRinaldi, F. / George, E. / Longson, C. et al. | 2012
- A318
-
PHP169 Comparing the Hungarian Methodological Guideline for Conducting Economic Evaluation of Health Care Intervention with European GuidelinesHuszti, Z. / Nagy, B. Z. et al. | 2012
- A319
-
PHP174 Physical Activity Matters: The Associations Between Body Mass Index, Physical Activity and Health-Realted Quality-of-Life Trajectories Over 10 YearsFeeny, D. H. / Garner, R. / Bernier, J. / Thompson, A. / Mcfarland, B. H. / Huguet, N. / Kaplan, M. S. / Ross, N. A. / Blanchard, C. et al. | 2012
- A322
-
PHP190 Global Pharmaceutical Risk-Sharing Agreement Trends in 2011 and 2012: Slowing Down?Ando, G. / Izmirlieva, M. / Honoré / A. C. et al. | 2012
- A323
-
PHP195 Adoption of New Technologies in Twenty Established and Emerging MarketsHertz, D. / Marcarelli, A. D. / Patel, L. / Garfield, S. et al. | 2012
- A324
-
PHP201 Can Risk Management Plans (RMP) Contribute to Health Technology Assessment (HTA) and Knowledge of Safety in Everyday Medical Practice?Prieto, L. / Spooner, A. / Hidalgo-Simon, A. / Rubino, A. / Kurz, X. / Arlett, P. et al. | 2012
- A325
-
PHP206 Assessing the Value of Access to Individual Patient Data for Reimbursement DecisionsManca, A. et al. | 2012
- A326
-
PGI5 Effectiveness and Safety of Antacids in Pregnant Women Suffering From Gerd/Hyperacidity SymptomsDonde, S. et al. | 2012
- A328
-
PGI18 Cost-Effectiveness of Boceprevir in Combination With Pegylated Interferon Alfa and Ribavirin for the Treatment of Genotype 1 Chronic Hepatitis C: Submission to the National Institute for Health and Clinical Excellence (NICE)Humphreys, S. C. / Elbasha, E. H. / Ferrante, S. A. / Lion, M. / O'Regan, C. et al. | 2012
- A329
-
PGI23 Cost-Effectiveness of Episodic or Maintenance Infliximab Versus Standard Treatment in an Incidence Cohort of Crohn's Disease Patients With 10-Years Follow-UpOdes, S. / Greenberg, D. / Vardi, H. / Friger, M. / Stockbrugger, R. / Munkholm, P. et al. | 2012
- A330
-
PGI27 Impact of Linaclotide Treatment on Work Productivity and Activity Impairment in Adults With Irritable Bowel Syndrome With ConstipationBuono, J. L. / Tourkodimitris, S. / Sarocco, P. / Baird, M. J. / Johnston, J. M. / Carson, R. et al. | 2012
- A331
-
PGI32 New Antiviral Drugs for Hepatitis C in Italy: Will it be a Treasure Hunt?Gardini, I. / Fontana, R. / Fumagalli, M. / Conforti, M. / Lanati, E. P. et al. | 2012
- A332
-
PGI37 Finalisation and Psychometric Validation of a new Questionnaire Measuring Patient Satisfaction With Anti-TNF Treatments in Severe Crohn's DiseaseArnould, B. / Fofana, F. / Gilet, H. / Colombel, J. F. / Faure, P. / Hagè / ge, H. / Nachury, M. / Nahon, S. / Tucat, G. et al. | 2012
- A333
-
PMH2 Interim Results From the “AUTOR” Study, a European Observational Study in Pediatric Patients With Attention Deficit/Hyperactivity Disorder: Patient Characteristics and 1-Year CostsHaynes, V. / Quail, D. / Lorenzo, M. / Deix, C. / Anand, H. et al. | 2012
- A334
-
PMH8 Cost of Methylphenidate and Atomoxetine Prescribing to Children and Adults in South AfricaTruter, I. et al. | 2012
- A335
-
PMH13 Longitudinal Analysis of Patient Level Health Care Costs in Patients With Major Depressive Disorder Treated With DuloxetineCui, Z. / Faries, D. E. / Shen, W. / Able, S. L. / Novick, D. et al. | 2012
- A336
-
PMH18 Treatment Patterns and Costs in Patients With Schizophrenia in GermanyZeidler, J. / Heres, S. / Mahlich, J. C. / Greiner, W. et al. | 2012
- A337
-
PMH23 A Cost-Effectiveness Analysis of the Long-Acting Antispychotic Drugs Paliperidone Palmitate, Olanzapine Pamoate and Risperidone in the Treatment of Schizophrenia in FinlandEinarson, T. R. / Pudas, H. / Zilbershtein, R. / Jensen, R. / Nielsen, A. T. / Piwko, C. / Hemels, M. / Vincente, C. et al. | 2012
- A338
-
PMH28 Using Cost-Effectiveness Analysis to Define the Optimal Group of Patients to Benefit From Risperidone Long-Acting InjectableValencia-Mendoza, A. / Herná / ndez-Garduñ / o, A. et al. | 2012
- A339
-
PMH33 Cost Effectiveness of Paliperidone Palmitate Versus Oral Medication in the Treatment of Schizophrenia in AustriaWalter, E. / Dragosits, A. / Said, M. et al. | 2012
- A340
-
PMH38 Assessing Depressive Symptoms in Primary Care: Psychometrical Properties of the Spanish Version of the Clinically Useful Depression Outcome ScaleAgü / era, L. / Monton, C. / Maurino, J. / Medina, E. / Diaz, H. / Cuervo, J. et al. | 2012
- A341
-
PMH43 Modelling the Longitudinal Latent Effect of Pregabalin on Self-Reported Changes in Sleep Disturbances and Disability in Outpatients With Generalized Anxiety Disorder (GAD) Treated in Routine Clinical Practice in SpainRuiz, M. A. / Alvarez, E. / Carrasco, J. L. / Olivares, J. M. / Pé / rez, M. / Rejas, J. et al. | 2012
- A342
-
PMH48 Public Beliefs and Attitudes About Schizophrenia, Major Depression and Psychotropic MedicationRefaï / T. / Millier, A. / Toumi, M. / Ré / muzat, C. / Angermeyer, M. C. et al. | 2012
- A343
-
PMH54 ADHD Among Adults in Five Western European Countries: An Analysis of National Health and Wellness Survey DataAble, S. L. / Haynes, V. / Annunziata, K. / Upadhyaya, H. / Deberdt, W. et al. | 2012
- A344
-
PMD1 Economic Value of Screening for Early Parkinson's Disease in a European SettingJohnson, S. / Birnbaum, H. G. / Kaltenboeck, A. / Diener, M. / Siderowf, A. et al. | 2012
- A345
-
PMD6 Extracorporeal Photopheresis for the Treatment of Patients With Acute or Chronic Graft Versus Host Disease (GvHD), Refractory to Corticosteroids – A Sytematic ReviewWalczak, J. / Miernik, K. / Kuter, I. / Ussowicz, M. et al. | 2012
- A346
-
PMD12 A Budget Impact Model to Investigate Potential Cost Savings Associated With the Use of Safety-Engineered Sharp Devices in BelgiumHanmore, E. / Ruff, L. / Maclaine, G. D. / Garin, F. / Leroy, N. et al. | 2012
- A347
-
PMD17 Use of Sterrad® Sterilizers Results in Cost-Savings Compared to Steam Sterilization in an Italian Hospital SettingPerrone, F. / Zenna, G. / Mauro, E. / Hamerslag, L. / Emmermann, A. et al. | 2012
- A349
-
PMD28 Comparing the Cost and Diagnostic Efficiency of Gadoxetic Acid-Enhanced MRI Versus Extracellular Contrast Media-Enhanced MRI and Multidetector Computed Tomography in Patients With Suspected Hepatocellular Carcinoma in Thailand and KoreaHoltorf, A. P. / Bergmann, K. / Kim, M. J. / Phongkitkarun, S. / Sobhonslidsuk, A. / Rinde, H. / Lee, J. M. et al. | 2012
- A350
-
PMD33 The Impact of Three Different Imaging Strategies on Surgery Planning for Patients With Colorectal Cancer Liver MetastasesRinde, H. / Zech, C. J. / Jonas, E. / Bergmann, K. / Holtorf, A. P. et al. | 2012
- A351
-
PMD38 The Cost Burden of Unexplained Syncope in Five European Countries: A Database AnalysisEggington, S. / Tsintzos, S. / Collignon, C. / Borghetti, F. / Martí / B. / Sicras-Mainar, A. et al. | 2012
- A352
-
PMD44 Evaluating Strategies for Using DNA Testing to Identify Mucinous Pancreatic CystsMyers, J. A. / Klein, R. W. / Han, X. / Al-Haddad, M. A. / Smolen, H. J. et al. | 2012
- A354
-
PMD55 Sacral Nerve Modulation (SNM) for the Treatment of Idiopathic Refractory Overactive Bladder: Cost-Effective in the UK Compared to Optimal Medical Therapy, Botulinum Toxin a (BoNT-A) and Percutaneous Tibial Nerve Stimulation (PTNS)Walleser, S. / Betts, C. / Hallas, N. / Ockrim, J. et al. | 2012
- A355
-
PMD61 Cost-Effectiveness of Positron Emission Tomography in Head and Neck Squamous Cell Carcinoma: A Systematic ReviewZaim, R. / Redekop, W. K. / De Bree, R. / Van Dongen, G. A. / Hoekstra, O. S. / Uyl-de Groot, C. A. et al. | 2012
- A357
-
PMD72 The Use of Multi-Criteria Decision Analysis to Elicit Colorectal Cancer Screening PreferencesHummel, J. M. / Steuten, L. / Groothuis-Oudshoorn, K. G. / Mulder, N. / IJzerman, M. J. et al. | 2012
- A358
-
PMD77 Contribution of Individual EQ-5D Dimensions to Improved Quality of Life After Balloon Kyphoplasty for Vertebral Compression FracturesBorgströ / m, F. / Aghayev, E. / Olafsson, G. / Miltenburger, C. et al. | 2012
- A359
-
PMD82 Implantable Cardioverter Defibrillator in Italy From 2000 to 2008: A Population-Based Analysis Using Health Administrative DatabasesMadotto, F. / Fornari, C. / Conti, S. / Borghetti, F. / Mantovani, L. G. / Cesana, G. et al. | 2012
- A360
-
PMD88 Disparities in Access to EGFR-Mutation Testing in Patients With Advanced NSCLC in Germany 2011Kellermann, L. / Ukena, D. et al. | 2012
- A362
-
PCV6 Comparison Rivaroxaban with Other Antithrombotic Agents: Effectiveness and Safety of Prophylactic Antithrombotic Agents After Major Orthopedic Surgeries in TaiwanChang, W. Y. / Hsu, H. C. / Wu, C. H. / Chen, P. S. / Wu, M. T. et al. | 2012
- A363
-
PCV11 Indirect Treatment Comparison (ITC) of Novel Oral Anticoagulants for the Prevention of Thromboembolic Events in Patients With Atrial FibrillationPechlivanoglou, P. / Le, H. H. / Engelfriet, P. M. / Redekop, W. K. / Postma, M. J. et al. | 2012
- A364
-
PCV16 Use of ACE Inhibitors in Serbia in 2009 and 2010Milijasevic, B. / Tomic, Z. / Sabo, A. / Horvat, O. et al. | 2012
- A365
-
PCV22 A Simple Risk Score Identifies Individuals, in European Settings, More Likely to Incur Higher Medical CostsGuda, S. / Alperin, P. / Schuetz, C. A. et al. | 2012
- A366
-
PCV27 Pharmacoeconomic Evaluation of Neuroprotective Therapy of Patients With Acute Ischemic Stroke in UkraineMishchenko, O. / Iakovlieva, L. / Adonkina, V. / Chinush, I. / Matyashova, N. et al. | 2012
- A367
-
PCV32 The Cost of Diabetes Complications in BelgiumLamotte, M. / Chevalier, P. et al. | 2012
- A369
-
PCV43 Fair Cost-Benefit Evaluation of Health Care: A Case Study of Blood Pressure Lowering Drugs in FranceDormont, B. / Fleurbaey, M. / Luchini, S. / Samson, A. L. / Schokkaert, E. / Thé / baut, C. / Van de Voorde, C. et al. | 2012
- A370
-
PCV48 Systematic Review of Cost-Effectiveness Models for Pharmacologic Stroke Prevention in Atrial FibrillationLimone, B. / Baker, W. L. / Roberts, M. / Coleman, C. I. et al. | 2012
- A371
-
PCV53 Economic Evaluation of a Single Pill Triple Antihypertensive Therapy With Valsartan, Amlodipine, and Hydrochlorothiazide Against Its Dual Components in GreeceStafylas, P. / Kourlaba, G. / Hatzikou, M. / Georgiopoulos, D. / Maniadakis, N. et al. | 2012
- A373
-
PCV65 A Health Economic Evaluation of Omega-3 Acid Ethyl Esters 90 in the Secondary Prevention Post-MIGerlier, L. / Vellopoulou, K. / Lamotte, M. / Lacey, L. / Einroos, A. / Carr, E. et al. | 2012
- A374
-
PCV70 Cost-Effectiveness of Smoking Cessation Interventions in Smokers With Cardiovascular Disease in the NetherlandsMajer, I. M. / Rozenbaum, M. H. / Verheggen, B. et al. | 2012
- A376
-
PCV82 Observational Study Evaluating the Level of Compliance With Antihypertensive Drugs in the Greek PopulationGeorgiopoulos, D. / Hatzikou, M. / Demousis, F. / Sakalides, C. et al. | 2012
- A377
-
PCV87 Factors Related to Non-Adherence and Satisfaction for Hypertension Medications: Results From a Novel Patient RegistryKamble, S. / Cascade, E. / Gemmen, E. et al. | 2012
- A378
-
PCV92 Comparison of the Psychometric Properties of the Cambridge Pulmonary Hypertension Outcome Review (CAMPHOR) and the SF-36 in Patients with Pulmonary HypertensionTwiss, J. / Ganderton, L. / Jenkins, S. / Ben-L'amri, M. / Gain, K. / Fowler, R. / Gabbay, E. / McKenna, S. et al. | 2012
- A379
-
PCV97 Burden of Dyspepsia among Patients With Atrial Fibrillation in JapanKinoshita, Y. / DiBonaventura, M. D. / Wang, E. C. / Rossi, B. / Iwamoto, K. / Stankus, A. / Briere, J. B. et al. | 2012
- A380
-
PCV102 Characteristics Influencing Japanese Atrial Fibrillation Patients Preferences for Anticoagulants UseOkumura, K. / Inoue, H. / Yasaka, M. / Gonzalez, J. M. / Hauber, A. B. / Iwamoto, K. / Wang, E. C. / Rossi, B. / Briere, J. B. et al. | 2012
- A381
-
PCV108 Analysis of Outpatient Utilization and Costs of Antithrombotic Drugs in Poland – Implications for Pharmaceutical Pricing and Reimbursement PolicyBochenek, T. / Nizankowski, R. et al. | 2012
- A382
-
PCV113 The Utilisation of Statins in Slovak RepublicGatialova, K. / Bellova, K. / Foltan, V. / Majtá / s, J. et al. | 2012
- A383
-
PCV119 Retrospective Analysis of Pharmaceutical Expenditures in 2011 in the Republic of SrpskaGuzvic, V. / Zah, V. et al. | 2012
- A385
-
PIN7 Efficacy of Ceftaroline Fosamil and Other Intravenous Antibiotics in the Treatment of Complicated Skin and Soft Tissue Infections (CSSTI): A Network Meta-Analysis (NMA)Medic, G. / Karabis, A. / Borrill, J. / Worrall, J. / Bergman, G. et al. | 2012
- A386
-
PIN12 Burden of Disease and Serotype Distribution Associated With Reportable Invasive Streptococcus Pneumoniae Pneumonia in Norway, 2007–2009Raluy, M. / Gray, S. / Lambrelli, D. / Eriksson, D. / Samantha, M. / Wasiak, R. / Myrvang, B. et al. | 2012
- A387
-
PIN17 Tuberculosis Treatment Outcomes in Four States of MalaysiaKhan, A. H. / Syed Sulaiman, S. A. / Abdul Muttalif, A. R. / Hassali, M. A. / Ahmad, N. et al. | 2012
- A388
-
PIN22 Economic Impact of 13-Valent Pneumococcal Conjugate Vaccine (PCV13) in Persons Over 50 Years of Age With Underlying Chronic Medical Conditions in FinlandMartikainen, J. A. / Soini, E. J. / Laine, J. / hman, H. / Postila, V. / Klemets, P. et al. | 2012
- A390
-
PIN33 Corsar-Study (Cost and Resource Utilisation Study in Antiretroviral Treated Patients)Stoll, M. / Kuhlmann, A. / Hower, M. / Heiken, H. / Gerschmann, S. / Klauke, S. / Lutz, T. / Bogner, J. / Degen, O. / van Lunzen, J. et al. | 2012
- A391
-
PIN38 Real Life Study of Antifungal Treatment in Greek ICUs: Therapeutic Strategy and Hospital Resource Utilization – Estimator StudyArmaganidis, A. / Nanas, S. / Antoniadou, E. / Mandragos, K. / Liakou, K. / Kostagiolas, L. / Koutsoukou, A. / Baltopoulos, G. / Nakos, G. / Magkina, A. et al. | 2012
- A392
-
PIN43 The Use of Futility Rules in Economic Evaluations With Direct Acting Agents (DAA) in the Treatment of Genotype 1 Hepatitis C Virus (HCV) From a Spanish Health Care PerspectiveD'Angelo, E. R. / Garcia Gonzalez, I. / Simon, M. A. et al. | 2012
- A393
-
PIN48 Cost-Efectiveness Analysis of Darunavir Versus Atazanavir, Each in Combination With Emtricitabine and Tenofovir, for the Management of Naive Anti-Retroviral HIV Infected Patients, Under the Belgian Social Security PerspectiveSantos, M. / Stenut, S. / Ferraq, W. / Legrand, J. C. / Tilleul, P. / Borget, I. et al. | 2012
- A394
-
PIN53 The Cost Effectiveness of Maternal and Infant Antiretroviral Regimens to Prevent Vertical Transmission in a Resource Poor CountryRevill, P. / Walker, S. / Sculpher, M. J. / Merry, C. / Barry, M. / Ryan, M. et al. | 2012
- A395
-
PIN59 Cost-Effectiveness of Amoxicillin Clavulanate Directed Towards the Application of Indicated at Primary Care in the Treatment of Community Acquired Pneumonia, Acute Rhinosinusitis, Tonsillopharyngitis, and Acute Otitis MediaMalhan, S. / Oksuz, E. / Eray, O. / Koc, E. et al. | 2012
- A396
-
PIN64 Assessing the Cost-Effectiveness (CE) of Vaccinating the Elderly and at-Risk Adults With the 23-Valent Pneumococcal Polysaccharide Vaccine (PPV23) Compared to the 13-Valent Pneumococcal Conjugate Vaccine (PCV13) or no Vaccination (NoVac) in the UKJiang, Y. / Gauthier, A. / Keeping, S. T. / Carroll, S. M. et al. | 2012
- A397
-
PIN69 Cost Utility Analysis of 13-Valent Pneumococcal Conjugate Vaccine in MalaysiaWu, D. B. / Lee, K. K. / Lee, V. W. / Hong, L. W. / Roberts, C. S. et al. | 2012
- A398
-
PIN74 Cost Savings Due to Antibiotic Prescription Related to Quick C-Reactive Protein TestingTesar, T. / Babela, R. et al. | 2012
- A399
-
PIN80 Multivariate Cox Analysis Regarding Treatment Switch on Chronic Hepatitis B (CHB) Disease Management Based on a 2-Year Prospective Study in 5 European (EU) CountriesArama, V. / Zeuzem, S. / Leblebicioglu, H. / Simon, K. / Klauck, I. / Morais, E. / Lescrauwaet, B. / Kamar, D. / Zarski, J. et al. | 2012
- A401
-
PIN90 Towards Best Practices for Handling Uncertainties in Health Technology Assessments for HPV Vaccination to Better Inform Decision MakingSiebert, U. / Castellsague, X. / Lee Mortensen, G. / La Torre, G. et al. | 2012
- A402
-
PSU5 Bariatric Surgery From the Perspective of Brazilian National Health System (SUS)Freitas, M. G. / Souza, K. M. / Silva, M. T. / Elias, F. T. et al. | 2012
- A403
-
PSU10 Costs of Cardiovascular Readmissions Following Percutaneous Coronary Intervention in Patients With Chronic Kidney Disease: Data From a Large Multi-Centre Australian RegistryAriyaratne, T. V. / Ademi, Z. / Duffy, S. J. / Andrianopoulos, N. / Billah, B. / Brennan, A. L. / Clark, D. J. / New, G. / Black, A. / Ajani, A. E. et al. | 2012
- A404
-
PSU15 Clinical and Economic Burden of Anastomotic Leaks After Colorectal SurgeriesLim, S. / Hammond, J. / Wan, Y. / Gao, X. / Patkar, A. et al. | 2012
- A405
-
PSU21 Sentinel Lymph Node Biopsy Less Expensive Than Axillary Lymph Node Dissection in Early Breast Cancer StagingRaimond, V. et al. | 2012
- A406
-
PSU26 Health-Related Quality of Life in Familial Amyloidotic Polyneuropathy Before and After Liver Transplantation: A Systematic Literature ReviewAmaral, L. M. / Fernandes, R. A. / Vasconcellos, J. F. / Takemoto, M. / Fujii, R. K. / Furlan, F. / Mould, J. et al. | 2012
- A407
-
PSU31 The Association Between Degenerative Disk Disease and Outcomes Among Patients Undergoing Lumbar Fusion SurgeryLage, M. J. / Kemner, J. E. / Mccormack, M. / Treglia, M. et al. | 2012
- A408
-
PCN1 Use of the 5-HT3-RA Antiemetics in the Prevention and Treatment of Radiation Induced Nausea and VomitingKnoth, R. L. / Faria, C. / Chang, E. / Broder, M. et al. | 2012
- A409
-
PCN6 The Evaluation of the Use and Effectiveness of Bevacizumab for Patients With Metastatic Renal Cell Carcinoma in Daily Practicede Groot, S. / Redekop, W. / Oosting, S. / Oosterwijk, E. / Kiemeney, L. / Uyl-de Groot, C. et al. | 2012
- A410
-
PCN11 The Impact of Treatment Persistence With Lenalidomide (LEN) for the Treatment of Multiple Myeloma (MM) on Disease ControlHenk, H. / Kaura, S. / Khan, Z. / Teitelbaum, A. et al. | 2012
- A411
-
PCN17 Indirect Comparison of the Efficacy of Erlotinib Versus Pemetrexed Plus Cisplatin as First Line Treatment in Patients With Metastatic Non Small Cell Lung Cancer With Epidermal Growth Factor Receptor Activating MutationsPereira, C. / Sanches, M. / Loff, J. F. et al. | 2012
- A413
-
PCN29 Initial Treatment and Survival Among Elderly Patients With Advanced Breast Cancer by Estrogen Receptor and Progesterone Receptor Status: An Analysis of United States National Registry Data 2000-2009Lang, K. / Huang, H. / Namjoshi, M. / Federico, V. / Menzin, J. et al. | 2012
- A414
-
PCN34 Relationship Between Progression-Free Survival and Overall Survival in Chronic Lymphocytic LeukemiaBeauchemin, C. / Johnston, J. / Lapierre, M. E. / Aissa, F. / Lachaine, J. et al. | 2012
- A416
-
PCN45 Economic Evaluation of Using Branded Taxotere® Versus Generic Docetaxel: Based on Decision Tree ModelAl Ameri, M. N. / Tucker, A. / Johnston, A. et al. | 2012
- A417
-
PCN50 Treatment Patterns, Health Care Utilization, and Costs of Ovarian Cancer in Central and Eastern Europe Using a Delphi Panel Based on a Retrospective Chart ReviewKim, K. / Hernlund, E. / Justo, N. / Hernadi, Z. / Pete, I. / Ré / vé / sz, J. / Szá / nthó et al. | 2012
- A418
-
PCN56 Preliminary Results from a Study of Hospital Costs Due to Treatment of Head and Neck Cancers in EnglandTempest, M. J. / Thurston, S. / Carroll, S. M. / Keeping, S. T. et al. | 2012
- A419
-
PCN61 Melody Brazil – Resource Use and Associated Costs With Metastatic Melanoma in Brazilian Health Care SystemStefani, S. D. / Nita, M. E. / Nunes, J. / Campos, E. / Schmerling, R. A. / Barrios, C. / Dzik, C. / Alves, J. S. / Johnston, K. / Donato, B. M. et al. | 2012
- A420
-
PCN66 Cost-Effectiveness of Denosumab Versus Zoledronic Acid for Skeletal-Related Event (SRE) Reduction in Bone-Metastatic Prostate Cancer (mPC) in the UKBotteman, M. F. / Carter, J. A. / Fishman, P. / Chandiwana, D. / Bains, M. / Snedecor, S. J. et al. | 2012
- A421
-
PCN71 Cost-Effectiveness Analysis of Cetuximab and Panitumumab as First-Line Therapies for Metastatic Colorectal Cancer in SpainMoreno, V. / Martí / nez-Amores, B. / Barriuso, J. / Mezquita, L. / Ibá / ez de Cá / ceres, I. / Ayuso, x. / Peñ et al. | 2012
- A422
-
PCN76 Cost-Effectiveness of Erlotinib as First-Line Maintenance Therapy for Advanced Non-Small-Cell Lung Carcinoma in Patients EGFR WT and Stable Disease After Four Cycles of ChemotherapyCobo, M. / De Castro, J. / Isla, D. / Oyagü / ez, I. / Lozano, V. / Castro-Gomez, A. et al. | 2012
- A423
-
PCN81 Cost Effectiveness of Pazopanib in Soft Tissue SarcomaAmdahl, J. / Manson, S. / Isbell, R. / Chit, A. N. / Diaz, J. R. / Lewis, L. / Delea, T. E. et al. | 2012
- A424
-
PCN86 Cost-Effectiveness Analysis of Abiraterone for the Treatment of Advanced Prostate Cancer Under the Brazilian Private Health Care SystemPereira, M. L. / Bahmdouni, L. S. / Pepe, C. / Teich, V. et al. | 2012
- A426
-
PCN97 Pharmacoeconomic Analysis of the Prostate Cancer Therapy with Gonadotropin-Releasing Hormone Analogues: Leuprorelin, Goserelin, TriptorelinOmelyanovsky, V. / Avxentyeva, M. / Ivakhnenko, O. / Khailov, P. / Krysanov, I. / Maksimova, L. et al. | 2012
- A427
-
PCN102 The Cost of Absenteeism and Short-Term Disability Associated With Colorectal Cancer: A Case-Control StudyYaldo, A. / Seal, B. / Lage, M. J. et al. | 2012
- A428
-
PCN107 Persistence in First Line Treatment of Metastatic Renal Cell Carcinoma in Routine Care in GermanyMergenthaler, U. / Morawski, E. / Wendschlag, A. et al. | 2012
- A429
-
PCN112 Characteristics of Cancer Patients Who Seek Cytostatic Therapy in Korea: A Pilot StudyKim, E. H. / Park, S. / Lee, J. S. / Choi, H. S. / Kim, K. S. / Kim, S. / Choi, W. C. et al. | 2012
- A430
-
PCN117 Quality of Life in Patients With Malignant Ascites After Treatment With Catumaxomab: A Multicenter Phase II/III Study Comparing Paracentesis Plus Catumaxomab With Paracentesis AloneSalek, M. S. / Deger, M. / Wimberger, P. / Gilet, H. / Parsons, S. L. et al. | 2012
- A431
-
PCN122 Pilot Survey to Estimate Willingness to Pay (WTP) for Prophylactic Granulocyte Colony-Stimulating Factors (G-CSFs) Among Previously Treated Breast Cancer PatientsJohnson, P. / Bancroft, T. J. / Barron, R. / Legg, J. / Watson, H. / Naeim, A. / Watkins, A. / Marshall, D. et al. | 2012
- A432
-
PCN127 Policy Maker, Please Carefully Consider Your Needs: Does Outcomes Research of Bortezomib for Advanced Multiple Myeloma Reduce Uncertainty?Franken, M. G. / Gaultney, J. G. / Blommestein, H. M. / Huijgens, P. C. / Sonneveld, P. / Redekop, W. K. / Uyl-de Groot, C. A. et al. | 2012
- A433
-
PCN133 Utilisation of Antineoplatic Agents Involved in Treatment of NSCLC in Slovak Republic Within 2008-2011Bellova, K. / Gatialova, K. / Foltan, V. / Majtá / s, J. et al. | 2012
- A434
-
PCN138 Patterns of Anticoagulant Use in Cancer Patients Receiving ChemotherapyZong, J. H. / Eckert, L. / Zhang, L. / Dai, W. S. / Lyman, G. H. / Cohen, A. T. et al. | 2012
- A435
-
PCN143 Utility Data in Appraisals of Oncology Drugs by the UK National Institute for Health and Clinical ExcellenceProudfoot, C. et al. | 2012
- A436
-
PCN149 Uncertainty Regarding NICE's End-of-Life Small Patient Population CriteriaMoï / se, P. / Sweeney, N. / Holmstrom, S. et al. | 2012
- A437
-
PCN154 Are Population-Based Registries a Suitable Tool for Outcomes Research in Cancer? Experiences from Four Registriesde Groot, S. / Blommestein, H. / Franken, M. / Uyl-de Groot, C. et al. | 2012
- A438
-
PCN159 Melody Brazil - Treatment Patterns in Brazilian Health Care SystemSchmerling, R. A. / Barrios, C. / Nita, M. E. / Stefani, S. D. / Campos, E. / Nunes, J. / Biasi, L. / Lima, L. / Dzik, C. / Johnston, K. et al. | 2012
- A439
-
PMS5 Benefit-Risk Analysis of Adalimumab and Alternative Treatments for Moderate-to-Severe Rheumatoid ArthritisHicks, K. A. / Earnshaw, S. R. / Shaw, J. W. / Cifaldi, M. et al. | 2012
- A440
-
PMS10 Comparing Costs of Anti-TNF Therapy by Adminstration Route for Patients With Ankylosing Spondylitis and Rheumatoid Arthritis in France in 2012: A Budget Impact ModelChevreul, K. / Bourguignon, S. / Granados, D. et al. | 2012
- A442
-
PMS21 Determinants of Total Health Care Costs Associated With Rheumatoid Arthritis Prevalent Cases in TurkeyBaser, O. / Burkan, A. / Baser, E. / Koselerli, R. / Ertugay, E. / Altinbas, A. et al. | 2012
- A443
-
PMS26 Assessment of the Burden of Rheumatoid Arthritis in France: Analysis of a National Representative Claim DatabaseFagnani, F. / Laurendeau, C. / Fautrel, B. / Joubert, J. M. / De chalus, T. / Gourmelen, J. et al. | 2012
- A444
-
PMS31 Economic Evaluation of Adalimumab Versus Other Biologic Treatments for Moderate to Severe Psoriatic Arthritis in ItalyMarcellusi, A. / Bansback, N. / Rao, S. / Cifaldi, M. / Gitto, L. / Giannantoni, P. / Russo, S. / Mennini, F. S. et al. | 2012
- A445
-
PMS36 Cost-Effectiveness of Denosumab for the Treatment of Elderly Women With Post-Menopausal Osteoporosis in SwedenLundkvist, J. / Lö / thgren, M. / Badamgarav, E. / Freyschyss, B. et al. | 2012
- A446
-
PMS41 Cost-Effectiveness of Denosumab in Preventing Osteoporotic Fractures in Postmenopausal Women from the Private Health Care Setting Perspective in BrazilBarbosa, E. G. / Machado, M. / Araú / jo, G. T. / Etto, H. / Fonseca, M. / Olimpio, A. et al. | 2012
- A448
-
PMS52 Drug Use Profile in a Rheumatoid Arthritis Patient Cohort: A Brazilian Health Management Organization ExperienceCantanheda, C. R. / Simas, H. S. / Dias, Q. C. et al. | 2012
- A449
-
PMS57 Effect of Different Methods on Estimating Persistence to Oral Bisphosphonate Therapy in Portuguese PMO Patients – an Observational Prospective StudyGuerreiro, J. / Torre, C. / Mendes, Z. / Machado, M. / Ferreira, I. / Feudjo-tepie, M. / Canhã / o, H. / Branco, J. / Miranda, A. et al. | 2012
- A450
-
PMS62 Nominal Group Technique to Select Attributes for Discrete Choice ExperimentsHiligsmann, M. / Van durme, C. / Geusens, P. / Dellaert, B. / Dirksen, C. / Van der Weijden, T. / Reginster, J. Y. / Boonen, A. et al. | 2012
- A451
-
PMS67 Long-Term Benefits of 4-Weekly Certolizumab Pegol Combination and Monotherapy on Household Productivity and Social Participation in Rheumatoid Arthritis: 5 Year Results from an Open Label Extension StudyStrand, V. / Purcaru, O. / Van vollenhoven, R. / Choy, E. / Fleischmann, R. et al. | 2012
- A452
-
PMS72 Adherence and Change of Opioid Use After Initiating Duloxetine or Celecoxib Among Patients With OsteoarthritisPeng, X. / Wu, N. / Chen, S. Y. / Yu, X. / Andrews, J. S. / Novick, D. et al. | 2012
- A453
-
PMS77 Real-World Comparison of Health Care Utilization Between Duloxetine Initiators and Pregabalin Initiators Among Fibromyalgia PatientsPeng, X. / Sun, P. / Wu, A. / Andrews, J. S. / Novick, D. / Faries, D. / Sun, S. et al. | 2012
- A454
-
PMS82 US Treatment Patterns in Psoriatic Arthritis Newly Initiated on Etanercept or AdalimumabZhang, F. / Li, S. / Curtis, J. R. et al. | 2012
- A455
-
PUK5 Employment Rates and Indirect Costs in Patients With End-Stage Renal Disease: Differences Between Modalities of Renal Replacement TherapyJuliá / n, J. C. / Cuervo, J. / Rebollo, P. / Castejó / n, N. / Callejo, D. et al. | 2012
- A456
-
PUK10 Comparative Cost-Analysis of Six Anticholinergics for the Treatment of Overactive Bladder and Incontinence in GermanyMayrhofer, T. / Grabe, K. / Felder, S. et al. | 2012
- A457
-
PUK15 Sevelamer in Early Stages Nondialysis-Dependent Chronic Kidney Disease (NDD-CKD) Dominates Calcium Carbonate Through Reduction of Deaths and HospitalizationsRuggeri, M. / Di Iorio, B. et al. | 2012
- A458
-
PUK21 Conversion From Epoetin Alfa to Darbepoetin Alfa in Hemodialysis Patients With Chronic Kidney Disease: French Monocentre Observational StudyBinaut, R. / Bacri, J. L. / Fleury, D. / Maisonneuve, N. / Labatut, D. / Lemaitre, V. / Medeghri, Z. / Bir, G. / Lanier, J. et al. | 2012
- A459
-
PRM1 Kaplan-Meier Survival Curves: A Potential Source of Data for Systematic ReviewsGupta, J. / Bhutani, M. K. / Kumar, R. / Kaur, M. / Jindal, R. / Siddiqui, M. K. et al. | 2012
- A460
-
PRM6 The UK Contribution to Real World Research: Review of Published Data at ISPOR, Madrid 2011Peperell, K. / Lones, R. / Devlin, N. et al. | 2012
- A461
-
PRM11 Real-World Data to Calculate Cost-Effectiveness of Monoclonal Antibodies: Problems and Solutionsvan Rooijen, E. M. / van der Linden, N. / van Gils, C. / Oppe, M. / Uyl-de Groot, C. et al. | 2012
- A462
-
PRM16 Access to Cost Data Capture Using Public Database, Website and Literature in Germany, France, Spain and USAAlvarez-Ossorio, L. / Ezzat, N. / Cariou, Y. / Tarab, A. et al. | 2012
- A463
-
PRM22 The Headroom Method of Early Economic Evaluation of Medical Devices: A Useful Tool for Device Developers?Chapman, A. M. / Taylor, C. A. / Girling, A. J. et al. | 2012
- A464
-
PRM27 Evaluating European Data Sources for Assessing Real-World Effectiveness of New Anti-Diabetic DrugsMoï / se, P. / Andreykiv, M. / van Engen, A. / Wimbush, A. J. / Richards, A. / Ploug, U. J. et al. | 2012
- A465
-
PRM33 Real World Evidence: Promise and Pitfalls of Real World DataWeir, S. / Langham, S. / Ratcliffe, M. et al. | 2012
- A466
-
PRM38 Estimation of a Markov Chain for Crohn's Disease and Classification of Patients Into Disease Phenotypes, in Eight Countries Using Individual Longitudinal Data Aggregated Over TimeBorg, S. / Gerdtham, U. G. / Rydé / n, T. / Munkholm, P. / Odes, S. / Langholz, E. / Moum, B. / Annese, V. / Bagnoli, S. et al. | 2012
- A467
-
PRM43 A Systematic Review on the Application of Cardiovascular Risk Prediction Models in Pharmacoeconomics, With a Focus on Primary PreventionStevanovic, J. / Postma, M. J. / Pechlivanoglou, P. et al. | 2012
- A468
-
PRM48 The Half-Cycle “Correction”: How Much of a Correction is it?Taylor, M. / Lewis, L. et al. | 2012
- A469
-
PRM54 Correlating Cost Effectiveness Output With Patient Level Data Input via the IMS Core Diabetes Model (CDM)McEwan, P. / Foos, V. / Lloyd, A. / Palmer, J. L. / Lamotte, M. / Grant, D. et al. | 2012
- A470
-
PRM59 Methods for Discounting in Economic Evaluation; An Empirical Comparison of Preferences in Money and Quality of LifeParouty, M. / Krooshof, D. / Westra, T. / Postma, M. et al. | 2012
- A471
-
PRM65 A Minimal Information Decision-Analytic Approach to Early HTA of Diagnostic TestsKoffijberg, H. / Moons, K. G. / de Wit, G. A. et al. | 2012
- A472
-
PRM70 What If All Other Things are Not Equal? – Accounting for Future Changes in the Decision Context When Extrapolating Cost-Effectiveness Results Over TimeAsaria, M. / Palmer, S. et al. | 2012
- A473
-
PRM75 Parallel Sets as Interactive Visualization Approach for Analyzing Markov ModelsUrach, C. / Piringer, H. / Popper, N. / Breitenecker, F. et al. | 2012
- A475
-
PRM86 Utilizing Indirect Treatment Comparisons in Metastatic Castration Resistant Prostate Cancer (mCRPC)Wasiak, R. / Joulain, F. / Lambrelli, D. / Trask, P. C. / Sartor, O. et al. | 2012
- A476
-
PRM91 How Do Patients With Different Conditions Describe Their Pain?Martin, M. L. / Scanlon, M. / McCarrier, K. P. / Wolfe, M. / Bushnell, D. M. et al. | 2012
- A477
-
PRM96 Reliability of a Patient-Reported Adverse Drug Event Questionnairede Vries, S. T. / de Zeeuw, D. / Haaijer-Ruskamp, F. M. / Denig, P. et al. | 2012
- A478
-
PRM101 A Think Aloud Study Comparing the Validity and Acceptability of Discrete Choice and Best Worst Scaling MethodsWhitty, J. A. / Walker, R. / Golenko, X. / Ratcliffe, J. et al. | 2012
- A479
-
PRM106 Examination of Preferences Elicited From the General Public: Comparisons of Results From the Time Trade-Off and Standard Gamble InstrumentsIskedjian, M. / Navarro, V. / Farah, B. / Berbari, J. / Walker, J. H. / Lelorier, J. et al. | 2012
- A480
-
PRM111 Pediatric Patient-Reported Outcomes Assessment: A Case Study in Epidermolysis BullosaMordin, M. / Clark, M. / Doward, L. / Willian, M. K. et al. | 2012
- A481
-
PRM116 Payer and Patient Perceptions of Medication Value and the Role of Patient-Reported OutcomesCascade, E. / Andreykiv, M. / Istas, A. et al. | 2012
- A482
-
PRM122 Atopic Dermatitis on Families: Creation of a Specific Burden QuestionnaireMeni, C. / Bodemer, C. / Toulon, A. / Branchoux, S. / Taieb, C. et al. | 2012
- A483
-
PRM128 Development of a Translation Evidence Tracking Tool to Comply With the FDA Review Requirements for the Translation of PRO InstrumentsMear, I. / Anfray, C. / Conway, K. et al. | 2012
- A484
-
PRM134 Regression Methods for Health-Related Quality of Life Data in Longitudinal Settings: Are More Advanced Techniques Really Performing Better?Hunger, M. / Dö / ring, A. / Holle, R. et al. | 2012
- A485
-
PRM139 Including Patients in Multiple Groups and Multiple Times in the Same Group in Longitudinal Observational Research: A Cystic Fibrosis ExamplePasta, D. J. / Millar, S. J. et al. | 2012
- A486
-
PRM144 Cardiologists' Knowledge and Awareness of Guidelines for Medical Device Safety and Product Risk ManagementBozkurt, R. / Yildirim, J. et al. | 2012
- A487
-
PRM150 Latent Transition Analysis as a Tool for Analysing Clinical DataMayer, D. / Burgess, A. J. et al. | 2012
- A488
-
PRM155 A Pragmatic Randomized Clinical Trials – Design and Quality Assessment of the Source of Effectiveness DataKaczynski, L. / Solnica, B. et al. | 2012
- A489
-
PRM160 A New Value-Based Pricing Framework for the Optimal Pricing of Pharmaceutical AssetsHawryluk, E. A. / Malhotra, M. / Chawla, V. / Doyle, J. et al. | 2012
- A491
-
PRM171 Optimal Shopping: An Evauation of Decision Rules in Cost-Effectiveness Analysis (CEA)McKenna, C. / Claxton, K. et al. | 2012
- A492
-
PRM177 What is the Role of Early Health Technology Assessment of Biomarkers in the Pre-Clinical Development Phase? A Reflection on Lessons Learned With Multiple MyelomaGaultney, J. G. / Redekop, W. K. / Sonneveld, P. / Uyl-de Groot, C. A. et al. | 2012
- A493
-
PDB4 HbA1C Reduction Associated With Initial Versus Sequential Combination Therapy With Pioglitazone (PIO) and Dipeptidyl Peptidase-4 Inhibitors (DPP4i) in Patients With Type 2 Diabetes Mellitus (T2DM)Bron, M. / Chen, K. / Ayyagari, R. / Sharma, H. / Wu, E. Q. et al. | 2012
- A494
-
PDB9 Outcome of Fixed Dose Radioactive Iodine for the Treatment of HyperthyroidismObidiya, S. O. / Ogunjobi, K. / Eniojukan, J. F. et al. | 2012
- A495
-
PDB14 Characteristics of the Aboriginal People with Diabetes in the South-Western of Ontario, Canadareza Nakhai-Pour, H. / Tarride, J. E. / Blackhouse, G. / Xie, F. / O'Reilly, D. / Goeree, R. / Petrella, R. J. et al. | 2012
- A496
-
PDB19 A Systematic Review of Recent Data Describing the Risk of Complications in Type 1 Diabetes Mellitus PatientsPearson, I. / Wolowacz, S. / Irving, A. / Brockbank, J. / Chubb, B. / Gundgaard, J. / Briggs, A. / Davies, M. J. et al. | 2012
- A497
-
PDB25 Evaluation of Health Care Cost of Diabetes Before and After Counseling in South Indian Community SetupMateti, U. V. / Akari, S. / Adla, N. et al. | 2012
- A498
-
PDB30 The Pattern and Prescription Cost Among Diabetic Patients in the HO Municipal Hospital, Volta Region, GhanaOkotah, A. N. et al. | 2012
- A499
-
PDB35 Evaluation of the Long Term Economic Impact of Improving Hba1C in Type 2 Diabetes Patients in Saudi ArabiaTodorova, L. / Baabbad, R. / Smith-palmer, J. / Al-mansari, A. et al. | 2012
- A500
-
PDB41 Long-Term Evaluation of the Economic Impact of Reducing HbA1C by 1% in Type 2 Diabetes Patients in AlgeriaRoca, P. / Lamri, L. / Belhadj, M. / Pollock, R. F. / Valentine, W. J. / Todorova, L. et al. | 2012
- A501
-
PDB46 Anti-Diabetic Drugs and In-Patient Admissions Attributable to Diabetes in PortugalGouveia, M. / Laires, P. / Borges, M. / Augusto, M. / Martins, A. P. et al. | 2012
- A502
-
PDB51 Resource Utilization in the Management of Acromegaly: An Analysis From Southwest OntarioPetrella, R. J. / Van uum, S. / Hurry, M. et al. | 2012
- A503
-
PDB56 Development and Validation of Patient Reported Endpoints for T2DMBron, M. / Hudgens, S. / Stokes, J. / Banderas, B. / Viswanathan, P. / Dabbous, O. et al. | 2012
- A504
-
PDB61 Research on the Incidence and Cost of Hypoglycemia Episode in Patients With Type 2 Diabetes Mellitus (T2DM)Zheng, Y. / Wu, J. / sterle, A. et al. | 2012
- A506
-
PDB73 Obesity and Frequent Hypoglycemia in European Type 2 Diabetes PatientsVietri, J. / Isherwood, G. / Le pautremat, V. / Eschwè / ge, E. M. et al. | 2012
- A507
-
PDB78 Determinants of Treatment Changes of Oral Anti/Diabetic Drugs in the UKMaguire, A. / Mitchell, B. et al. | 2012
- A508
-
PSY4 Lenalidomide or Bortezomib for the Treatment of Relapsed/Refractory Multiple Myeloma (MM): A Comparative Effectiveness Analysis Using Indirect Statistical TechniquesKaura, S. / Dranitsaris, G. et al. | 2012
- A509
-
PSY10 An Indirect Comparison of Icatibant and Four Other Therapies for the Symptomatic Treatment of Acute Attacks of Hereditary Angioedema Types I and IIHelbert, M. / Pang, F. / Alvarez-Reyes, M. / Roskell, N. S. / Diwakar, L. et al. | 2012
- A510
-
PSY15 Impact of Chronic Immune-Mediated Inflammatory Diseases on Work Productivity: Literature ReviewGranados, D. / Depont, F. / Chevreul, K. et al. | 2012
- A511
-
PSY20 Cost-Effectiveness of Prophylaxis With an Anti-Inhibitor Complex Concentrate in Patients With Haemophilia and Inhibitors: Results From Pro-Feiba StudyGringeri, A. / Leissinger, C. / Cortesi, P. A. / Cristiani, M. / Fusco, F. / Mantovani, L. G. et al. | 2012
- A512
-
PSY25 Etanercept in Early Rheumatoid Arthritis: Economic Evaluation From the Public Payer Perspective in BrazilTakemoto, M. / Fernandes, R. A. / Fujii, R. K. / Mould, J. / Tang, B. et al. | 2012
- A514
-
PSY35 Assessment of the Most Bothersome Symptoms and Impacts Reported by Patients With Chronic Low Back PainRamasamy, A. / Blum, S. I. / Liedgens, H. / Martin, M. L. / McCarrier, K. P. / Quintanar-Solares, M. / Argoff, C. / Freynhagen, R. / Patrick, D. L. / Wallace, M. S. et al. | 2012
- A515
-
PSY40 Health-Related Quality of Life and Annual Direct Medical Cost of Patients With Haemophilia B in France: The EQOFIX StudyPolack, B. / Calvez, T. / Claeyssens, S. / Chambost, H. / Derlon, A. / Goudemand, J. / Rothschild, C. / Maurel, F. / Woronoff-Lemsi, M. C. et al. | 2012
- A516
-
PSY45 Social Economic Burden and Health-Related Quality of Life in Patients With Rare Diseases in Europe (BURQOL-RD Project). Spanish ResultsLinertová / R. / Ló / pez-Bastida, J. / Serrano-Aguilar, P. / Posada-de-la-Paz, M. et al. | 2012
- A517
-
PHS1 The Effect of Positioning and PNF-Exercise to Postoperative Bleeding After Hip ReplacementGombos, G. / Steinhausz, V. / Bajsz, V. / Sió / E. / Turcsanyi, K. / Molics, B. / Boncz, I. / Schmidt, B. et al. | 2012
- A519
-
PHS12 Meta-Analysis of Parkinson's Disease Risk With Hypertension, Serum Total Cholesterol, and Diabetes MellitusMounika, P. / Venkat, A. / Chaitanya, P. / Dev, K. et al. | 2012
- A520
-
PHS17 Costs of Influenza A(H1N1)2009 Infection During the Pandemic and the Postpandemic-Seasonal WavesGarin, O. / Galante, M. / Hollmann, M. / Sicuri, E. / Cots, F. / Garcia-Alté / s, A. / Ferrer, M. / Dominguez, x. / Castilla, J. et al. | 2012
- A521
-
PHS22 Burden of Invasive Pneumococcal Diseases in Older Adults in the New EU Countries of the Central EuropeTichopad, A. / Roberts, C. S. / Skoczynska, A. / Hryniewitz, W. / Gembula, I. / Hajek, P. / Krizova, P. / Motlova, J. / Avdicova, M. et al. | 2012
- A522
-
PHS28 The Cost of Management of Patients With Atrial Fibrillation : An Observational Study in UK NHS Primary CareKassianos, G. / Fuat, A. / Arden, C. D. / Hogan, S. / Baldock, L. et al. | 2012
- A523
-
PHS33 Cost Analysis of Dialysis Practice in TurkeyTatar, M. / Ergin oguzhan, G. / Kockaya, G. et al. | 2012
- A524
-
PHS39 Cost-Effectiveness of a Nurse-Led Integrated Chronic Care Approach Versus Usual Care in Patients With Atrial FibrillationHendriks, J. M. / Tomini, F. / Van asselt, A. D. et al. | 2012
- A525
-
PHS44 Economic Evaluation of Universal Hepatitis B Vaccination Strategy in JapanHirao, T. / Sato, T. / Sugimori, H. / Suka, M. / Yoda, T. / Yoshioka, A. / Akazawa, M. / Igarashi, A. / Kobayashi, M. / Ikeda, S. et al. | 2012
- A526
-
PHS49 Cost of Hypoglycaemia in Patients With Diabetes in PolandWidz, K. / Czech, M. / Hermanowski, T. et al. | 2012
- A527
-
PHS54 Use of Health Care Administrative Databases to Estimate the Health Care Burden of Bone or Bone Marrow Metastatic Deases in Breast Cancer Patients: A Population-Based StudyMantovani, L. G. / Scalone, L. / Furneri, G. / Ciampichini, R. / Cortesi, P. A. / Fornari, C. / Madotto, F. / Chiodini, V. / Cesana, G. et al. | 2012
- A528
-
PHS60 Health-Related Quality of Life in HIV/HCV Co-Infected Patients in IrelandMcgreal-bellone, A. / Cleary, S. / Farrell, G. / Bergin, C. / Barry, M. / Kieran, J. et al. | 2012
- A529
-
PHS65 Mapping the Disease-Specific FACT-P to the Preference-Based EQ-5D in Castration-Resistant Prostate CancerIvanescu, C. / Skaltsa, K. / Holmstrom, S. et al. | 2012
- A530
-
PHS70 Health Related Quality of Life As Predictor of Death Among Patients With Heart FailureEscobar, A. / Bilbao, A. / Gonzalez-Saenz de Tejada, M. / Fernandez-soto, M. / Lafuente, I. / Sanchez-haya, E. / Citores, L. et al. | 2012
- A531
-
PHS76 An Infuenza Vaccination Policy Based on a Previous Year's IllnessYamin, D. / Gavious, A. / Solnik, E. / Davidovitch, N. / Pliskin, J. S. et al. | 2012
- A532
-
PHS81 Health Care Organizations/Services Clustering: Comparison of Several Techniques Using UK DataMillier, A. / Mejri, S. / Aballea, S. / Toumi, M. et al. | 2012
- A533
-
PHS87 Cost of Diabetes in Insulin-Treated Patients in BulgariaDoneva, M. / Valov, V. / Borissova, A. M. / Tankova, T. / Savova, A. / Manova, M. / Petrova, G. / Czech, M. et al. | 2012
- A534
-
PHS93 HbA1c Test Utilization Among Hospitalized Patients With HyperglycemiaEby, E. / Gelwicks, S. / Marchlowska, P. A. et al. | 2012
- A535
-
PHS98 Clinical Characteristics, Treatment Patterns, and Resource Utilization in a Real-World European Population With DiverticulitisDavis, K. L. / Mitra, D. / Yen, L. et al. | 2012
- A536
-
PIH5 Preventable Drug-Related Hospital Visits and Admissions Associated with Laboratory or Physiologic Abnormalities - A Systematic-ReviewWilbur, K. / Hazi, H. / El-Badawi, A. et al. | 2012
- A538
-
PIH16 Epidemiology of Herpes Zoster and Its Related Resource Utilization: A Large Population-Based Study in IsraelWeitzman, D. / Shavit, O. / Stein, M. / Shay, N. / Cohen, R. / Chodick, G. / Shalev, V. et al. | 2012
- A539
-
PIH22 Clinical Efficacy and Cost-Effectiveness of Human Recombinant Interferon-α2B in Neonatal InfectionsSoldatova, I. / Pankratyeva, L. et al. | 2012
- A540
-
PIH27 Cost Analysis of Neonatal and Pediatric Parenteral Nutrition in BelgiumWalter, E. / Dragosits, A. / Noerens, K. / De Bosscher, H. / Blom, H. / Maton, P. et al. | 2012
- A541
-
PIH32 The Impact of Periods on Women's Quality of Life in Women Reporting a ProblemPumford, N. / Muston, D. / Wade, A. / Crawford, G. / Young, D. et al. | 2012
- A542
-
PIH37 Trends of Quality of Life in South Korean Adults During 2007-2010Chang, C. W. / Choi, I. S. / Lee, S. M. / Suh, D. C. et al. | 2012
- A543
-
PIH43 Comparison of Unintended Pregnancy Rates Among Women Who Initiated Oral Contraceptive Therapy with a 84/7 Estradiol or a 84/7 PlaceboBrewster, C. / Lage, M. J. / Grubb, E. et al. | 2012
- A544
-
PIH48 Service Uses and Costs of Child and Adolescent Psychiatric Patients Treated with Antipsychotics in TaiwanChang, H. C. / Mccrone, P. / Su, K. P. et al. | 2012
- A545
-
PND2 Effect of Cognitive Behavioural Therapy in Multiple Sclerosis Fatigue: A Systematic Review of Randomised Controlled TrialsKohli, I. S. / Kataria, A. / Singla, S. / Kaushik, P. / Jindal, R. / Aggarwal, A. et al. | 2012
- A546
-
PND7 Off-Label Use of Antiepileptic Drugs and its Costs – a Drug Utilization Study in PortugalAfonso-Silva, M. / Oliveira-Martins, S. / Cabrita, J. et al. | 2012
- A547
-
PND13 Budget Impact Analysis and Update of a Cost Effectiveness Evaluation for Alpha (α) Polymorph Rifaximin for the Treatment of Acute Hepatic EncephalopathyCardona, D. P. / Zapata, L. / Ceballos, M. / Diez, F. / Rico, I. / Zavala, A. et al. | 2012
- A548
-
PND18 Impact of Co-Morbidities on the Economic Burden of Parkinson'S Disease in Germany Post-2000Takyar, S. / Kataria, A. / Rajput, A. / Kaur, M. et al. | 2012
- A550
-
PND29 Cost Evaluation of Multiple Sclerosis at Different Stages in IranKhanizadeh, H. et al. | 2012
- A552
-
PND40 Cost-Utility Analysis of Fingolimod in Brazilian Patients With Multiple SclerosisSilva, N. L. / Takemoto, M. L. / Cruz, R. B. / Suzuki, C. et al. | 2012
- A553
-
PND45 Differential Outcomes in Patients With Alzheimer'S Disease (AD) Treated With Donepezil 23Copher, R. / Li, X. / Powers, A. / Clionsky, E. et al. | 2012
- A554
-
PND50 Estimation of the Effect of Dalfampridine Extended Release on Health Utility in Patients With Multiple Sclerosis Using Two Equations for Mapping the MSWS-12 to the EQ-5DLimone, B. / Sidovar, M. / Gaebler, J. A. / Lee, S. / Coleman, C. I. et al. | 2012
- A556
-
PND60 Non-Diabetic Peripheral Neuropathic Pain is Underdiagnosed in GP Practices Although it has High Impact on Patients' Health Related Quality of LifeBrodszky, V. / Komoly, S. / Bereczki, D. / Embey-Isztin, D. / Gulá / csi, L. / Balogh, O. / V. Hevé / r, N. / Torzsa, P. et al. | 2012
- A557
-
PND66 Therapeutic Equivalence as a Means of Improving the Efficiency in the Treatment of Multiple SclerosisBautista Paloma, F. J. / Flores Moreno, S. / Ucles Sanchez, A. / Casado Chocan, J. / Jimenez Hernandez, D. et al. | 2012
- A558
-
PND71 Predictors of Treatment Class Choice in Parkinson's DiseaseGrubb, E. / Castelli-Haley, J. / Treglia, M. / Lage, M. J. et al. | 2012
- A559
-
PRS2 A Retrospective Epidemiologic Review of COPD in KoreaJoo, H. / Jung, K. S. / Jeung, J. et al. | 2012
- A560
-
PRS8 Burden of Exacerbations in Patients With COPD in the Netherlands: a Real-Life StudyOverbeek, J. A. / Balp, M. M. / Penning, F. J. / Dekhuijzen, P. N. / Herings, R. M. et al. | 2012
- A561
-
PRS14 Clinical and Pharmacoeconomic Aspects of Allergen Immunotherapy in the Slovak RepublicBielik, J. / Pruzinec, P. / Tor, P. et al. | 2012
- A562
-
PRS20 Cost-Benefit Analysis for a Treatment of Pulmonary Arterial HypertensionIskedjian, M. / Walker, J. H. / McLean, A. / Farah, B. / Berbari, J. / Watson, J. A. et al. | 2012
- A563
-
PRS25 Cost Analysis of Omalizumab Use in Patients With Severe Uncontrolled Asthma Within the Mexican Public Health Care SystemLemus-Carmona, E. / Reyes-Lopez, A. / Jimenez Aranda, P. et al. | 2012
- A564
-
PRS30 Cost-Effectiveness Analysis of 100% Whey-Based Partially Hydrolyzed Infant Formula Used for Prevention of Atopic Dermatitis in GermanyErdogan Ciftci, E. / Horodniceanu, E. G. / Botteman, M. F. / Detzel, P. / Verheggen, B. G. et al. | 2012
- A565
-
PRS35 The Economic Burden of HAE: Findings From the HAE Burden of Illness Study in Europe (HAE-BOIS-Europe)Aygö / ren-Pü / rsü / n, E. / Bygum, A. / Caballero, T. / Beusterien, K. / Hautamaki, E. / Musingarimi, P. / Wait, S. et al. | 2012
- A566
-
PRS41 Characteristics and Determinants of Palivizumab Use in the NetherlandsHouweling, L. M. / Penning-van Beest, F. J. / Bezemer, I. D. / van Lingen, R. A. / Herings, R. M. et al. | 2012
- A567
-
PRS46 Health Care Resource Use of Patients With Cystic Fibrosis (CF) in the UKLambrelli, D. / Wasiak, R. / Ingram, A. / Harrow, B. / Becker, C. / Eriksson, D. / Wyatt, H. et al. | 2012
- A569
-
PSS10 Economical Burden of Severe Visual Impairment and Blindness – a Systematic ReviewKö / berlein, J. / Beifus, K. / Finger, R. et al. | 2012
- A570
-
PSS15 A New Insight Into Cost-Effectiveness Analyses in Atopic Dermatitis: The Tacrolimus 0.1% Ointment Versus Ciclosporin ComparisonAlmeida, J. / Vandewalle, B. / Silva, M. J. / Fé / lix, J. et al. | 2012
- A571
-
PSS20 Cost-Utility Analysis of Treatments for Macular Edema Secondary to Retinal Vein OcclusionDuff, S. / Gricar, J. / Kymes, S. / Tran, I. / Turpcu, A. / Sternberg, G. et al. | 2012
- A572
-
PSS25 Validation of the Patient Benefit Index (PBI) for the Assessment of Patient-Defined Benefit in the Treatment of PsoriasisFeuerhahn, J. / Blome, C. / Radtke, M. A. / Augustin, M. et al. | 2012
- A576
-
ISPOR 15th Annual European Congress Disclosure Information for Research Presentations| 2012
- A587
-
ISPOR 15th Annual European Congress Research Abstracts Author Index| 2012
- A602
-
CN1 Statins and the Risk of Hepatocellular Carcinoma in Patients with Hepatitis B Virus InfectionTsan, Y. / Lee, C. / Wang, J. / Chen, P. et al. | 2012
- A603
-
DB2 Vitamin D Deficiency and Diabetes: Perceptions of Pharmacists and PhysiciansJalundhwala, F. / Majumdar, A. / Malthankar, S. / Jalundhwala, Y. et al. | 2012
- A604
-
HC3 The Process of Updating the Items of National Health Insurance Benefits Schedule in Taiwan: is It Fair and Legitimate?Lin, C. W. et al. | 2012
- A605
-
ME4 Using Discrete Choice Experiments to Value Health States for Economic Evaluation – the SF-6D in AustraliaNorman, R. / Viney, R. / Brazier, J. / Burgess, L. / Cronin, P. / King, M. / Ratcliffe, J. / Street, D. J. et al. | 2012
- A607
-
EX3 A Evaluation of the Effects from China Drug Policy Reform During 2009-2011: Some Success, Many Unintended EffectsGuan, Q. / Cai, J. / Dummett, H. / Tan, S. C. et al. | 2012
- A608
-
PR1 Does Medication Adherence Correlate With Health-Related Quality of Life? Findings From a Descriptive AnalysisSaleem, F. / Hassali, M. A. / Shafie, A. A. / Aljadhey, H. / Haq, N. / Atif, M. et al. | 2012
- A610
-
PHP8 Factors Associated with Unnecessary Use of Antibiotics in U.S. State Medicaid ProgramsLi, P. / Marcus, S. / Metlay, J. / Doshi, J. A. et al. | 2012
- A611
-
PHP14 The Implementation of Essential Medicine Policy in China: Pros and ConsHu, S. / Zhang, Y. / He, J. J. et al. | 2012
- A613
-
PHP25 Market Analysis of Antibiotics Consumption in Northern Part of Iran During 2001-2010Zaboli, P. / Ala, S. / Kebriaee Zadeh, A. / Abdollahiasl, A. / Nikfar, S. et al. | 2012
- A614
-
PHP30 The Utilization and Expenditure of Reimbursed Digestive Enzyme Agents in TaiwanYang, W. W. / Wang, Y. C. / Pwu, R. F. et al. | 2012
- A615
-
PHP36 Comparing Oral 5-Aminosalicylic Acid Treatment Persistence and Adherence in Patients with Ulcerative Colitis in the United StatesYen, L. / Wu, J. / Hodgkins, P. / Nichol, M. B. et al. | 2012
- A616
-
PHP41 Risk Management in Iranian Pharmaceutical Companies to Ensure Accessibility and Quality of MedicinesJaberidoost, M. / Abdollahiasl, A. / Farshchi, A. / Dinarvand, R. et al. | 2012
- A617
-
PHP47 Impact of Economic and Policy Factors on China'S Health Care ExpenditureZhang, J. / Ando, G. / Bharath, A. et al. | 2012
- A618
-
PHP53 Comparative Evaluation of Drug Information Sources Used by DoctorsKini, S. / Ankush, C. / Pratik, G. / Shahank, W. / Ligade, V. S. / Sreedhar, D. / Udupa, N. et al. | 2012
- A619
-
PHP60 Iranian Pharmacists' Job Satisfaction: Analysis Through Various Job CharacteristicsForoughi Moghadam, M. J. / Peiravian, F. / Naderi, A. / Mehralian, G. / Rasekh, H. et al. | 2012
- A621
-
PHP76 Evidence Requirements for Pricing and Reimbursement Decision Making for Orphan Drugs in AsiaTan, S. / Dummett, H. / Kirpekar, S. / Guan, Q. / Priest, V. L. et al. | 2012
- A622
-
PHP81 Factors Influencing Interprofessional Collaboration: A Literature Review from 2004-2011Chang, E. H. / Doucette, W. R. et al. | 2012
- A623
-
PHP87 Satisfaction Assessment of Insurance System for Urban Residents (URMS) of University Students in ShenyangZhang, F. / Li, S. C. / Du, J. et al. | 2012
- A625
-
PHP99 Implementation of a Formulary Management Programme in SingaporeZhao, Y. J. / Teng, M. / Khoo, A. L. / Lim, B. P. et al. | 2012
- A626
-
PHP108 Pattern of Antibiotics Usage in Malaysian Hajj PilgrimAbd Aziz, N. / Hassan, Y. / Hashim, H. / Malik Mansoor, S. / Abd Shatar, A. K. et al. | 2012
- A627
-
PHP113 Utilization of FPG, HbA1C and Self-Monitoring of Blood Glucose (SMBG) in Community Health Centers in the Shanghai AreaMast, O. / Tan, A. et al. | 2012
- A628
-
PHP118 The Attitude of Farmers to the New Rural Cooperative Medical Scheme in the Northwest of China: A Cross-Sectional StudyXu, C. / Gericke, C. A. et al. | 2012
- A629
-
PCV5 The Effeects of Statins on Blood Presure in Normotensive or Hypertensive Subjects-a Meta-Analysis of 18 Randomized Controlled Trials Involving 5628 ParticipantsBanach, M. / Nikfar, S. / Rahimi, R. / Mikhailidis, D. P. / Narkiewicz, K. / Rysz, J. / Abdollahi, M. et al. | 2012
- A630
-
PCV11 Use of Anti-Infectives for Systemic Administration in Serbia in 2010Milijasevic, B. / Tomic, Z. / Sabo, A. / Vukmirovic, S. et al. | 2012
- A631
-
PCV19 Hospitalization Costs and Their Predictors in Patients With Venous Thromboembolism in ChinaWu, J. / Yang, L. / Zhu, G. et al. | 2012
- A632
-
PCV26 Lifetime Cost-Effectiveness Analysis of Ticagrelor in Patients With Acute Coronary Syndromes Based on the Plato Trial: A Singapore Health Care PerspectiveChin, C. T. / Mellströ / m, C. / Chua, T. S. / Matchar, D. B. et al. | 2012
- A633
-
PCV31 Cost-Effectiveness of Apixaban Versus Enoxaparin for the Prevention of Postsurgical Venous Thromboembolism in KoreaOh, J. J. / Shin, H. H. / Jung, H. / Park, J. H. / Ko, S. K. et al. | 2012
- A634
-
PCV36 Validation 36 and Comparison of the SF-6D and EQ-5D in Chinese Patients With Stable Angina PectorisWu, J. / Han, Y. / Gao, Y. / Zhou, J. / Chen, Z. / Sun, H. et al. | 2012
- A635
-
PGI5 Increasing Demands for Medical and Drug Utilization in Patients With Long-Term Irritable Bowel Syndrome in TaiwanHsu, C. C. / Chen, L. C. / Wen, Y. H. et al. | 2012
- A636
-
PGI10 Factors Associated With Treatment Adherence and Persistence in Canadian Patients With Ulcerative Colitis (Uc): Analysis of Prescription Claims From the Ramq DatabaseLachaine, J. / Yen, L. / Beauchemin, C. / Hodgkins, P. et al. | 2012
- A637
-
PGI16 Treatment With Prucalopride for Chronic Constipation Improves the Symptoms and Quality of Life of Patients in ChinaKe, M. Y. / Zou, D. W. / Yuan, Y. Z. / Li, Y. Q. / Lin, L. / Ji, J. / Song, W. J. / Du, X. X. / Chang, J. H. et al. | 2012
- A638
-
PIH6 Cost-Effectiveness of Rotavirus Immunization in Vietnam: Exploring Impacts of Herd Immunity and Patterns of BreastfeedingofTu, H. A. / Coyte, P. / Li, S. C. / Postma, M. J. et al. | 2012
- A639
-
PIH12 A Descriptive Study of Health Related Quality of Life among General Population of Quetta, PakistanUl Haq, N. / Hassali, M. A. / Shafie, A. A. / Saleem, F. / Aljadhey, H. / Atif, M. / Iqbal, Q. et al. | 2012
- A640
-
PRS6 Self-Reported Adherence to Inhaled Corticosteroids and Beliefs About Medicines in Asthma Patients: A Study From Emergency Room of a Chest Hospital in Delhi, IndiaKotwani, A. / Shendge, S. et al. | 2012
- A641
-
PRS11 Assessment of Knowledge About Tuberculosis Among Libyan and Non Libyan Populations in North East LibyaSolliman, M. M. / Hassali, M. A. / Al-Haddad, M. S. / Atif, M. / Shafie, A. A. / Saleem, F. / Aljadhey, H. / Haq, N. et al. | 2012
- A642
-
PSS3 Medical Resource Use and Associated Costs in Open-Angle Glaucoma in 10 Asia-Pacific CountriesGerlier, L. / Lamotte, M. / Caputo, J. / Tan, R. et al. | 2012
- A643
-
PSS8 Health Burden of Vision Problems in Asia: A Study of Malays and Indians in SingaporeWang, X. / Ang, M. / Chiang, P. / Zheng, Y. / Cheng, C. Y. / Lamoureux, E. / Wong, T. Y. / Luo, N. et al. | 2012
- A644
-
PUK5 Clinical and Economic Impacts of Clinical Pharmacy Education on Infection Management Among Patents With Chronic Kidney Disease in a Hospital (Indonesia)Nasution, A. / Syed Sulaiman, S. A. / Shafie, A. A. et al. | 2012
- A645
-
PRM4 QALY and Productivity Loss: Empirical Evidence for “Double Counting”Shiroiwa, T. / Fukuda, T. / Shimozuma, K. / Ikeda, S. et al. | 2012
- A646
-
PRM11 Evidence for Validity of a National Patient-Reported Survey in Japan: The Japan National Health and Wellness SurveyDibonaventura, M. D. / Fukuda, T. / Stankus, A. et al. | 2012
- A647
-
PRM16 Evaluation of Personalized Breast Cancer Test-Treatment Strategies - A Cross-Validation Study Between a Discrete-Event Simulation and a Markov ModelJahn, B. / Rochau, U. / Arvandi, M. / Kuehne, F. / Kluibenschaedl, M. / Paulden, M. / Krahn, M. / Siebert, U. et al. | 2012
- A648
-
PRM21 Validity and Reliability of the 8-Item Morisky Medication Adherence Scale in Patients Taking Warfarin in SingaporeWang, Y. / Kong, M. C. / Ko, Y. et al. | 2012
- A650
-
PRM32 Reliability and Validity of an Instrument Used in a Tobacco Cessation Intervention Study Among Patients With DiabetesIbrahim, K. A. / Syed sulaiman, S. A. / Shafie, A. A. / Awaisu, A. / Lajis, R. / Nasution, A. et al. | 2012
- A652
-
PRM44 Clinical and Comparative Economic Value - A Novel Pharmacoeconomic Analysis Embedded in the Drug Development ProcessFang, X. / Seo, M. / Standing, M. / Xu, Z. / Jacobson, S. / Woolmore, A. et al. | 2012
- A653
-
PCN5 Impact of Erythropoiesis Stimulating Agents on Survival among Patinets With Colorectal Cancer Receiving ChemotherapySato, M. / Freedman, A. / Trovato, J. / Zhan, M. / Cunningham, F. / Weiss Smith, S. et al. | 2012
- A654
-
PCN10 Risk of Breast Cancer and Statins: A Population-Based Nested Case-Control Study in Chinese PopulationChan, A. L. / Leung, H. W. / Wang, J. J. et al. | 2012
- A655
-
PCN16 Comparison of the Efficacy and Cost of Novel Targeted Cancer TherapiesKaura, S. / Khan, Z. et al. | 2012
- A656
-
PCN22 Cost-Effectiveness Analysis of Cervical Cancer Screening With Self-Sampling for Human Papillomavirus (HPV) Testing in TaiwanTsai, B. C. / Chow, I. H. / Liao, C. H. / You, S. L. / Tang, C. H. / Pwu, R. F. et al. | 2012
- A657
-
PCN27 Disclosing Complementary and Alternative Medicines (CAM) Use to the Health Care Providers:A Descriptive StudyFarooqui, M. / Hassali, M. A. / Knight, A. / Akmal, A. / Farooqui, M. A. / Seang, T. B. et al. | 2012
- A659
-
PDB5 Statin is a Reasonable Treatment Option for Patients With Polysystic Ovary Syndrome: A Meta-Analysis of Randomized Controlled TrialsGao, L. / Li, S. C. et al. | 2012
- A660
-
PDB12 Role of Chromium in Type-2 Diabetes Therapy: A Systematic Review StudyFarshchi, A. / Seyedifar, M. / Abdollahiasl, A. / Nikfar, S. / Jaberidoost, M. / Esteghamati, A. / Abdollahi, M. et al. | 2012
- A661
-
PDB17 Comparison of Clinical and Economic Outcomes Associated With Dpp4 Inhibitors (DPP4I) Versus Sulfonylurea (SU) in Combination with Metformin (MET) or Pioglitazone (PIO) for the Treatment of Type 2 Diabetes Mellitus (T2DM)Bron, M. / Chen, K. / Cheng, D. / Bensimon, A. G. / Wu, E. Q. et al. | 2012
- A662
-
PDB22 The Direct Medical Cost for Diabetes Mellitus (DM) Related Complications in ChinaZheng, Y. / sterle, A. / Liu, X. / Wu, J. et al. | 2012
- A664
-
PDB33 Physician'S and Patient'S Perceptions and Beliefs Regarding Insulin Initiation and Use in Patients With Type 2 Diabetes (T2DM) in ChinaLiu, L. L. / Babineaux, S. M. / Kadziola, Z. / Brnabic, A. J. / Luo, T. et al. | 2012
- A665
-
PIN2 Assessing the Diagnostic Performance of Human Immunodeficiency Virus Type 1 (HIV-1) Tropism Testing Methods: A Systematic Review of Genotypic Sequencing of the Third Hypervariable (V3) Loop and Enhanced-Sensitivity Phenotypic Assay TechnologyNeedham, M. O. / Paech, D. / Norris, S. / Campbell, S. et al. | 2012
- A666
-
PIN7 Estimate of Infectious Disease Burden Attributable to Climate ChangePathak, P. / Rana, C. et al. | 2012
- A667
-
PIN13 Cost of Antibiotics Used for Nosocromaial Infection Treatment in Inpatient Department at Nakhon Pathom HospitalTewthanom, K. et al. | 2012
- A669
-
PMH6 Factors Associated with Medical Expenditure for Dementia in South KoreaJang, S. / Lee, T. J. / Yu, S. Y. et al. | 2012
- A670
-
PMH12 Medication Adherence, Diabetic Care and Risk of Acute Complications of Type II Diabetics with Schizophrenia Receiving Oral Hypoglycemic TherapyCheng, J. S. / Shih, Y. T. et al. | 2012
- A671
-
PMS5 A Randomized, Placebo Controlled Trial to Compare Safety and Efficacy Between Curcuma Longa Linn Extract [NR-INF-02], Glucosamine Sulphate and Combination of Two in the Treatment of Painful Knee OsteoarthritisKulkarni, C. / Madhu, K. / Saji, M. et al. | 2012
- A672
-
PMS12 Cost Implication of Prescriptions in Private and Public Health Institutions in Bayelsa State of NigeriaEniojukan, J. F. / Orumwense, D. O. / Obidiya, S. O. et al. | 2012
- A673
-
PMS17 Burden of Ankylosing Spondylitis in Urban ChinaTang, B. / Yang, L. / Liu, Y. / Chapnick, J. / Dong, P. / Wu, M. / He, S. et al. | 2012
- A674
-
PMS22 Improvement on Quality of Life and Daily Function in Rheumatoid Arthritis Patients Treated with Infliximab in ChinaHe, D. Y. / Chen, J. W. / Bi, L. Q. / Wu, L. J. / Lin, J. / Wang, N. S. / Li, J. G. / Yue, N. / Feng, W. W. et al. | 2012
- A675
-
PND5 Budget Impact of Oral Prolonged-Release Fampridine for Management of Walking Disability Associated With Multiple Sclerosis in TaiwanLee-Grossman, C. W. / Alexopoulos, S. T. / Murphy, D. R. et al. | 2012
- A676
-
PND11 Lacosamide for the Treatment of Partial Onset Seizures With or Without Secondary Generalisation: Cost-Effectiveness Analysis on Treating Patients With Lacosamide in Combination With a Non-Sodium Anti-Epileptic MedicationMakarounas-Kichmann, K. / Kirchmann, M. / Monin, N. et al. | 2012
- A677
-
PSY1 Burdens of Psoriasis in the Asia Pacific Region: A Literature ReviewSchenkel, B. / Leartsakulpanitch, J. / Yue, N. et al. | 2012
- A678
-
PSY7 Impact of Anti-Viral Treatment on the Economic Burden of Chronic Hepatitis B in TaiwanChen, P. J. / Chen, C. J. / Yang, H. I. / McLeod, E. / Heatley, R. et al. | 2012
- A679
-
PSY13 Systematic Review of the Economic and Epidemiological Burden of Bleeding-Related Complications in Hong KongTan, J. / Standfield, L. / Metz, L. et al. | 2012
- A680
-
PSY19 Access to Care and Health Outcomes Among the Hemophilia A Population in Developing Countries: A Comparison Between Philippines and ColombiaZhang, M. / Ito, D. / Xiong, Y. / Epstein, J. et al. | 2012
- A682
-
ISPOR 5th Asia-Pacific Conference Disclosure Information for Research Presentations| 2012
- A685
-
ISPOR 5TH Asia-Pacific Conference Research Abstracts Author Index| 2012
- i
-
Table of Contents| 2012
- III
-
Instructions for Authors| 2012
-
PHP19 Comprehensive Value Estimation of Adalimumab-Based Treatments: Covet StudyMarcellusi, A. / Gitto, L. / Giannantoni, P. / Russo, S. / Favato, G. / Mennini, F. S. et al. | 2012
-
PHP43 How Will Health Care Reform in Russia Affect Drug Pricing and Reimbursement?Wild, L. / Forster, L. et al. | 2012
-
PHP49 Irrational Use of Antibiotics in Children by Medical PrescribersJan, S. U. et al. | 2012
-
PHP58 Data Disclosure an Ongoing Process Towards More TransparencyAl Rabayah, A. A. et al. | 2012
-
PHP77 Health Expenditure and Drug Expenditure - Comparison of Two Western Balkans CountriesKrehic, J. / Gavrankapetanovic, F. / Bolanca, S. et al. | 2012
-
PHP98 Patients Preferences Versus Physicians Judgment: Is There a Difference in Health Care Decision Making?Mü / hlbacher, A. C. / Juhnke, C. et al. | 2012
-
PHP108 Early Access Programmes (EAPs): Review of Non- European SystemUrbinati, D. / Toumi, M. et al. | 2012
-
PHP131 Ensuring That Phase III Programs are Designed to Meet the Evolving HTA Requirements Across the EU5Lucas, F. / Secker-johnson, R. et al. | 2012
-
PHP144 Economic Effect of Clinical Trials for TurkeyKockaya, G. / Demir, M. / Uresin, A. Y. et al. | 2012
-
PHP149 Health Technology Assessment Evidence Criteria: What Types of Evidence Should Be Presented for Products Used to Screen for Disease in the United States?McGee, N. M. et al. | 2012
-
PHP170 The Swiss Health Technology Assessment (HTA) Consensus: Guiding PrinciplesSchlander, M. / Affolter, C. / Sandmeier, H. / Cueni, T. / Gyger, P. / Hebborn, A. / Herren, D. / Kaufmann, S. / Kraft, E. / Suter, P. et al. | 2012
-
PHP181 Costs/QALY Threshold in New Legislation and Its Impact on Access to Innovative Medicines in SlovakiaTomek, D. / Psenkova, M. / Tomekova, K. / Mackovicova, S. et al. | 2012
-
PHP185 The Pharmacists' and Patients' Side of Policy Measures in Pharmaceutical Markets: The Effects of Changing Pharmacy MarginsBarros, P. P. / Martins, B. / Moura, A. / Teixeira, I. / Costa, S. / Queiró / s, S. et al. | 2012
-
PHP187 Pharmacovigilance and the Case Study of VIOXXKrancberg, A. N. / Chmielewska, M. / Hermanowski, T. R. et al. | 2012
-
PIN26 Real Life Effectiveness of AntibioticsErdesz, D. / Kis, Z. et al. | 2012
-
PGI16 Cost Effectiveness of Boceprevir Plus Peginterferon Alpha and Ribavirin Versus Telaprevir Plus Peginterferon Alfa and Ribavirin in the Treatment of Chronic Hepatitis C (CHC) in Previously Untreated Genotype I PatientsFonseca, M. / Garran, V. / Araujo, G. T. et al. | 2012
-
PGI22 Cost-Effectiveness Analysis of Dexlansoprazole for the Treatment of Erosive Esophagitis Compared to Conventional Proton Pump InhibitorsValencia-Romero, A. / Gay-Molina, J. G. / Chiu-Ugalde, J. / Figueroa-Rodriguez, A. / Ló / pez-Alvarenga, J. C. / Sá / nchez-Kobashi, R. / Vargas, J. A. et al. | 2012
-
PGI28 Gastroesophageal Reflux Disease: Impact on Work Productivity and Daily Life Activities of Daytime Workers. A French Cross Sectional Study (ACTA)Bruley des Varannes, S. / Ducrotte, P. / Vallot, T. / Maurel, F. / Bardoulat, I. / Garofano, A. / Carrois, F. / Ricci, L. et al. | 2012
-
PGI31 Impact of Treatment Response on Health Utilities and Work Productivity Among Patients With Irritable Bowel Syndrome With Constipation: Pooled Results From Phase III Clinical TrialsHuang, H. / Taylor, D. / Carson, R. T. / Sarocco, P. / Menzin, J. et al. | 2012
-
PMH55 Payer Value in Alternative Treatment Formulations: Access to New Medicines in SchizophreniaMorawski, J. / Sweeney, N. / Nijhuis, T. et al. | 2012
-
PMD23 Long-Term Clinical Effectiveness and Cost-Effectiveness of Catheter-Based Renal Denervation in the UK. A Model-Based Projection Based on the Symplicity HTN-2 TrialPietzsch, J. B. / Geisler, B. P. / Akehurst, R. L. et al. | 2012
-
PMD27 Budget Impact of Selecting Cardiac Resynchronization Therapy (CRT) Devices With Adaptive (“ACRT”) Programming Algorithms Under the United States Medicare Payment SettingTarab, A. D. / Dougher, C. E. / Rogers, T. B. / Bril, S. L. / Tsintzos, S. / Goss, T. / Veath, B. K. et al. | 2012
-
PMD58 Cost-Effectiveness Analysis of Leprosy Case Detection Methods in Northern NigeriaEzenduka, C. C. / Post, E. / Namadi, A. / John, S. / Suraj, A. / Onwujekwe, O. et al. | 2012
-
PMD86 Inappropriate Use of Upper Gastrointestinal Endoscopy in Clinical Practices in JapanHamashima, C. / Goto, R. / Sano, H. et al. | 2012
-
PCV19 The Burden of Diabetes Mellitus in Belgium: A Retrospective Database StudyLamotte, M. / Chevalier, P. / Gerlier, L. et al. | 2012
-
PCV30 Assessment of the Hospital Costs of Mitral Regurgitation (MR) Patients, a French National Hospital Database AnalysisCros, S. / Levesque, K. / Bufi, L. / Caranhac, G. / Gotlieb, L. et al. | 2012
-
PCV50 Cost-Effectiveness Analysis of Treating Acute Coronary Syndrome Patients With Ticagrelor Versus Clopidogrel in Hong Kong: A Markov Analytic ModelLee, V. W. / Chow, I. H. / Yan, B. P. / Yu, C. M. / Lam, Y. Y. et al. | 2012
-
PCV55 A Cost-Effectiveness Analysis of Coralan® (Ivabradine) Plus Standard Care Versus Standard Care Alone in Chronic Heart FailureErgene, O. / Oto, A. / Cavusoglu, Y. / Aydogdu, S. / Ozdemir, O. / Tan, M. et al. | 2012
-
PCV59 Where Did the Time Go?: Temporal Uncertainty in Cost-Effectiveness Decision ModelsMahon, R. / Manca, A. / Palmer, S. et al. | 2012
-
PCV68 Economic Evaluation of Initiation With Endothelin Receptor Antagonists in the Treatment of Pulmonary Arterial Hypertension in SpainVilla, G. / Escribano, P. / Gil, J. / Roman, A. / Morano, R. et al. | 2012
-
PCV76 Standard Costs and Resources Allocation in Attainment of Target Lipid Levels among Experienced Statin Users: Results From the STAR Study (Statins Target Assessment in Real Practice)Degli Esposti, L. / Buda, S. / Sangiorgi, D. / Degli Esposti, E. et al. | 2012
-
PCV83 Adherence to Antihypertensive Agents After a Recent Ischemic Stroke and Risk of Cardiovascular Outcomes : A Population Based StudyPerreault, S. / Yu, A. Y. / Cô / té / R. / Dragomir, A. / White-guay, B. / Dumas, S. et al. | 2012
-
PCV86 The Burden of Non-Adherent Prescription Cost Cutting Among Diagnosed Hypertension Patients in RussiaGupta, S. / Vietri, J. / DiBonaventura, M. D. et al. | 2012
-
PCV105 The Importance of a Definition: Cost Implications for the UK of Alternative Definitions of HypercholesterolaemiaJameson, K. / D'Oca, K. / Amber, V. / Quoraishi, S. H. / O'Regan, C. et al. | 2012
-
PCV107 Generic Atorvastatin, the Belgian Statin Market and the Cost-Effectiveness of Statin TherapySimoens, S. / Sinnaeve, P. et al. | 2012
-
PCV115 Burden of Hypertension in Selected EU Countries: 2010-2025Eichmann, F. / Potthoff, P. / Schmidt, M. et al. | 2012
-
PCV118 Fixed-Dose Combinations and Their Value to PayersPrü / fert, A. / Andreykiv, M. / Nijhuis, T. et al. | 2012
-
PIN10 Fourth Year Post-Rotavirus Vaccination in Belgium: Decrease of Rotavirus-Positive Stool Samples in Hospitalised ChildrenStrens, D. / Raes, M. / Standaert, B. et al. | 2012
-
PIN13 The Clinical Burden of Hospitalized All-Cause Pneumonia in the Lombardia and Puglia Regions of Italy, 2007–2009Lambrelli, D. / Gray, S. / Wasiak, R. / Veronesi, C. / Raluy, M. / Munson, S. / Buda, S. / Icardi, G. et al. | 2012
-
PIN14 Projecting the Clinical Impact of Treating Hepatitis C Genotype 1 Infection With Boceprevir in GermanyBecker, B. / Chhatwal, J. / Ferrante, S. / Elbasha, E. H. / Krobot, K. J. et al. | 2012
-
PIN18 Rates of Influenza Complications by High Risk GroupMauskopf, J. / Lee, S. et al. | 2012
-
PIN28 Cost-of-Illness Analysis of Candidemia in Patients on the Intensive Care UnitHeimann, S. / Cornely, O. A. / Wisplinghoff, H. / Vehreschild, M. J. / Franke, B. / Glossmann, J. / Vehreschild, J. et al. | 2012
-
PIN35 Cost of Antimicrobial Prescribing Using a Large Pharmacy Database in South AfricaTruter, I. et al. | 2012
-
PIN39 A Cost Consequence Analysis of a Quadrivalent Meningococcal Vaccine (MenACWY-TT) in CanadaCognet, M. / Jiang, Y. / Parker, M. / Demarteau, N. / Bauch, C. T. et al. | 2012
-
PIN66 Cost Effectiveness Analysis of Vaccination With 13-Valent (PCV13) and 23-Valent (PPV23) Pneumococcal Vaccines for Senior Adults in São Paulo State, Brazil – Public PerspectiveFujii, R. K. / Roberts, C. S. / Mould, J. / Presa, J. / Jardim, E. / Manfrin, D. F. et al. | 2012
-
PIN76 Health Related Quality of Life of HIV Infected Intravenous Drug UsersSurah, S. / Adams, R. / Townsend, L. / Reynolds, I. / Delamere, S. / Kinahan, J. / Mulcahy, F. / Keenan, E. / Lyons, F. / Barry, M. et al. | 2012
-
PSU2 The Incidence of Complications After its Thyroidectomy in Patients With Thyroid Cancer in Korea : Using Health Claim DatabaseHyun, M. K. / Kim, J. / Kwon, J. W. / Park, Y. J. et al. | 2012
-
PSU1 3-Year Real-World Outcomes With the Swedish Adjustable Gastric Bandtm in FranceRibaric, G. et al. | 2012
-
PSU28 Retrospective Analysis of Liver Transplantation in BrazilFernandes, R. A. / Amaral, L. M. / Takemoto, M. M. / Takemoto, M. / Vasconcellos, J. F. / Cruz, R. B. / Cukier, F. N. / Furlan, F. / Fujii, R. K. / Mould, J. et al. | 2012
-
PCN36 Vinorelbine in Patients With Non-Small Lung Cancer: Budget Impact AnalysisVitezic, D. / Hadzic-Kostrencic, C. / Petkovic, M. / Dobrila-Dintinjana, R. / Vitezica, P. / Mrsic Pelcic, J. et al. | 2012
-
PCN44 Cost Comparison Analysis of Antibody Therapies in the Metastatic Colorectal CarcinomaMercsanits, D. / Said, M. / Dragosits, A. / Walter, E. et al. | 2012
-
PCN58 Health Economic Impact of Colorectal CancerKriza, C. / Wahlster, P. / Niederlä / nder, C. / Schaller, S. / Kolominsky-Rabas, P. et al. | 2012
-
PCN60 The Cost Study of Treating mCRC With Bevacizumab Plus Chemotherapy in the Real Clinical Practice in the Czech RepublicHradecka, I. / Rihova, B. / Horova, R. / Demlova, R. et al. | 2012
-
PCN82 Cost-Effectiveness Analysis of Erlotinib Versus Platinum Based Chemotherapy as First-Line Treatment of Non-Small Cell Lung Cancer EGFR Activating MutationsGarrido, P. / Ló / pez-Vivanco, G. / Rosell, R. / Espinó / s, B. / Castro-Gomez, A. et al. | 2012
-
PCN83 Cost Effectiveness Analysis in the Veneto Region of Cabazitaxel Versus Mitoxantrone in Patients with Metastatic Hormone Refractory Prostate Cancer, Previously Treated With a Docetaxel Containing RegimenMaran, P. R. / Aiello, A. / Magrì / M. R. / Alberti, C. / Visentin, E. / Venturini, F. / Scroccaro, G. et al. | 2012
-
PCN91 The Cost-Effectiveness of Trastuzumab Over the Product Life Cycle in Portugal: A Dynamic and Societal PerspectiveGarrison, L. / Babigumira, J. B. / Andrade, S. et al. | 2012
-
PCN116 Mapping FACT-P to EQ-5D in a Large Cross-Sectional Study of Metastatic Castrate-Resistant Prostate Cancer PatientsDiels, J. / Spencer, M. / Hamberg, P. / Wheatley Price, P. / Dass, R. N. et al. | 2012
-
PCN118 Impact of Bone Metastases on Quality of Life in Patients With Castration-Resistant Prostate Cancer (CRPC) at High Risk for Developing Bone MetastasesHechmati, G. / Arellano, J. / Haynes, I. / Gunther, O. / Worsfold, A. / Rider, A. et al. | 2012
-
PCN121 Decitabine Reduces Transfusion Dependence in Older Patients With Acute Myeloid Leukaemia: Results From a Post-Hoc Analysis of a Randomised Phase III TrialDass, R. N. / Howes, A. / Spencer, M. / Xiu, L. / Thomas, X. G. / Al-Dakkak, I. et al. | 2012
-
PCN125 Cost of Presenteeism Due to Cancer in PolandMacioch, T. / Hermanowski, T. R. et al. | 2012
-
PCN129 Emerging Market Access Trends: Pricing and Coverage of Targeted Cancer Therapies in Russia (2011-2012)Aggarwal, S. et al. | 2012
-
PMS3 Improvements in Patient-Reported Pain and Global Disease Activity in Rheumatoid Arthritis Patients After Treatment With NNC0109-0012 (Anti-IL-20 mAb) in a Phase 2A TrialSenolt, L. / Hansen, B. B. / Strandberg-Larsen, M. / Dokoupilová / E. et al. | 2012
-
PMS28 Cost-Benefit-Analysis of Thromboprophylaxis With Rivaroxaban and Certoparin-Sodium in Patients After Total Hip or Knee ReplacementHeidorn, K. / Mittelmeier, W. / Kundt, G. / Skripitz, R. et al. | 2012
-
PMS53 Association Between Teriparatide Adherence and Health Care Utilization and Costs in Real World United States Kyphoplasty/Vertebroplasty PatientsZhao, Y. / Johnston, S. S. / Smith, D. / Mcmorrow, D. / Krege, J. H. / Krohn, K. et al. | 2012
-
PMS58 Frequency of Administration of Biologics has an Impact on Treatment Decision MakingChevalier, P. / Black, C. M. / Lamotte, M. / Crombach, J. / Huismans, J. / Rosiek, R. / Fan, T. et al. | 2012
-
PMS75 Real-World Utilization Patterns of Rheumatoid Arthritis Medications in the United States: Anti-TNF Monotherapy and Adherence With Non-Biologic DMARDs in Combination with Anti-TNF TherapyEngel-nitz, N. M. / Ogale, S. / Kulakodlu, M. et al. | 2012
-
PUK6 The Economic Burden of Post-Transplant Events in Renal Transplant Patients in Germany (The Portrait Study)Neumayer, H. H. / Lopau, K. / Glander, P. / Detering, J. / Chamberlain, G. / Naik, M. / Plesnila-Frank, C. / Sabater, F. J. / Bennett, H. / Rosz, D. et al. | 2012
-
PUK13 Cost-Effectiveness of Ketosteril Treatment in Dialysis PatientsTó / th, E. / Nagy, B. et al. | 2012
-
PUK16 Cost-Effectiveness of Ketosteril Treatment in Stage 3-4 CKD PatientsTó / th, E. / Bacskai, M. / Nagy, B. / Lang, Z. et al. | 2012
-
PRM7 Increasing Physical Activity in Patients With Chronic Disease: What is the Literature Telling Us?Leidy, N. K. / Kimel, M. / Ajagbe, L. / Kim, K. / Hamilton, A. / Becker, K. et al. | 2012
-
PRM15 Assessing the Broader Impact of Vaccinations: A Government Perspective Quantitative Analytic Framework Applied to VaccinationKotsopoulos, N. / Connolly, M. / Postma, M. / Hutubessy, R. et al. | 2012
-
PRM53 Can the Disutility of Allergic Rhinitis and Conjunctivitis Be Calculated From the Aggregated Total Symptoms Score?Langkilde, L. K. / Volk, J. / Nø / rgaard Andreasen, J. et al. | 2012
-
PRM63 Long-Term Burden of Asthma in Children With Allergic Rhinitis/ ConjunctivitisLangkilde, L. K. / Andersen, L. / Nø / rgaard Andreasen, J. et al. | 2012
-
PRM84 Using Proportional Hazard Models to Predict Price Changes of Oncology Drugs in the United StatesWang, B. C. / Tsang, K. P. / Patel, P. et al. | 2012
-
PRM89 Standardizing the Metric and Increasing the Efficiency of Physical Functioning Outcomes MeasurementWare, J. / Guyer, R. / Harrington, M. / Boulanger, R. et al. | 2012
-
PR3 Drivers of Pricing and Market Access Decisions - Examples in Selected CountriesAssimakopoulos, M. / Jeffery, M. / Mukku, S. R. et al. | 2012
-
MA2 Observation of Persistence Rates and Potential Cost Savings Associated With Certolizumab Pegol Treatment for Rheumatoid Arthritis in England, Wales and Northern Ireland Clinical PracticeRussell, M. / Timoshanko, J. / Smets, E. / Duncan, G. / Spandley, A. / Roskell, S. et al. | 2012
-
CA1 Discordant Diagnoses in Sarcoma, GIST and Desmoide Tumour in France: Results From the Network RREPSPerrier, L. / Ranchr̀ / e Vince, D. / Terrier, P. / Neuville, A. / Decouvelaere, A. V. / Bui, B. / Le Cesne, A. / Ray Coquard, I. / Ducimetiè et al. | 2012
-
DU2 Contribution of Prolonged-Release Melatonin and Anti-Benzodiazepine Campaigns to the Reduction of Benzodiazepine and Z-Drug Consumption in Nine European CountriesClay, E. / Falissard, B. / Moore, N. / Toumi, M. et al. | 2012
-
RE3 How Will the New NHS Changes in England Impact the Implementation of Risk-Sharing Schemes for Oncology Treatments?Jeffery, M. / Assimakopoulos, M. / White, R. et al. | 2012
-
PHP3 Integration of Evidence on Patient Preferences in Health Care Decision Making: Current State of PlayUtens, C. M. / van der Weijden, T. D. / Joore, M. A. / Dirksen, C. D. et al. | 2012
-
PRM107 Nonprobability Versus Probability-Based Patient Sampling: Understanding Response Variation and ImplicationsSulham, K. / Peugh, J. / Edge, J. / DiSogra, C. A. / Garfield, S. et al. | 2012
-
PRM112 Recruitment Costs and Efficiency Varies With Condition/ Patient PopulationPumford, N. / Wade, A. / Crawford, G. et al. | 2012
-
PRM118 Methodology for Neuropsychological Assessment Wordlist AdaptationSimon, M. / Zarzar, K. / Settar, C. et al. | 2012
-
PRM125 Whose Values in Health? A Comparison of Adult and Adolescent Values for the CHU9D and AQOL-6DRatcliffe, J. et al. | 2012
-
PRM158 Placebo-Controlled Clinical Trials: A Difficult Balance “Justification Versus Feasibility” for Academic SponsorsDuracinsky, M. / Taron, C. / Matei, M. / Chassany, O. et al. | 2012
-
PRM162 Appropriate Comparative Treatments for Early Benefit Assessment (EBA) in Germany. Comparing the Suggestions by the Joint Federal Committee (GBA) and the Pharmaceutical CompaniesRuof, J. / Scherer, J. / Schulenburg, J. M. et al. | 2012
-
PRM164 Ensuring the Value of a Medical Device Innovation Prior to Market LaunchHidefjall, P. et al. | 2012
-
PRM169 Internal and External Validity in Economic Modeling: Considerations Based on a Published ExamplePorzsolt, F. et al. | 2012
-
PRM168 An Integrated Formal Framework for Reimbursement, Research and Pricing Deliberations in Health Technology AssessmentGriffin, S. / Spackman, E. / Soares, M. O. / McKenna, C. / Claxton, K. et al. | 2012
-
PDB6 Real-World Comparative Effectiveness Analysis of Patients Initiating Injectable Treatments for Type 2 Diabetes Mellitus (T2DM): Pilot Data From the Initiator StudyGrabner, M. / Wei, W. / Raparla, S. / Quimbo, R. A. / Cziraky, M. J. / Thayer, S. W. / Brekke, L. / Buysman, E. / Crown, W. / Hu, W. et al. | 2012
-
PDB15 Prevalence of Hypertension and/or Obesity in Patients With Type 2 Diabetes Mellitus Throughout the World: A Systematic Literature ReviewColosia, A. D. / Palencia, R. / Khan, S. et al. | 2012
-
PDB18 Population Attributable Risk of Microvascular Events Associated With HbA1C, Blood Pressure or Weight in Patients With Type 2 Diabetes MellitusHeintjes, E. / Penning-van Beest, F. J. / Parasuraman, S. V. / Grandy, S. / Pollack, M. / Herings, R. et al. | 2012
-
PDB24 Cost Analysis of Adding Pregabalin or Gabapentin to Usual Care in the Management of Community-Treated Patients With Painful Diabetes Peripheral Neuropathy in SpainSicras-mainar, A. / Rejas, J. / Navarro-artieda, R. / Planas, A. / Collados, C. et al. | 2012
-
PDB22 Potential Budget Impact of Linagliptin in France Estimated From Current Pattern of Dipeptidyl Peptidase 4 Inhibitors PrescriptionsColin, X. / Detournay, B. / Briand, Y. / Delaitre, O. et al. | 2012
-
PDB27 The Relationship Between the Presence of Metabolic Complications and Cost Components of Type 2 Diabetes Mellitus Patients in TurkeySatman, I. / Akalin, S. / Ozdemir, O. et al. | 2012
-
PDB26 Effect of Diabetes Disease Management Programs Based on Bundled Payment on Curative Health Care Costs in the NetherlandsMohnen, S. M. / Molema, C. C. / Baan, C. A. / de Jong-van Til, J. T. / Struijs, J. N. et al. | 2012
-
PDB43 Economic Evaluation of Vildagliptin Compared to Glimepiride as Add-on to Metformin for the Treatment of Diabetes Mellitus Type 2 Patients in GreeceHatzikou, M. / Rombopoulos, G. / Yfantopoulos, J. et al. | 2012
-
PSY9 Real-Life Cost-Analyses of Chronic Low-Back Pain Patients With Neuropathic Pain Components in DenmarkSæ / tterstrø / m, B. / Poulsen, P. B. / Olsen, J. / Strand, M. / Schiø / ttz-Christensen, B. et al. | 2012
-
PHS36 Cost Drivers of Household Treatment of Presumptive Malaria in Home-Based Management of Malaria in Ejisu-Juaben MunicipalityAgyei-baffour, P. / Asante, B. O. et al. | 2012
-
PHS75 Analysis of Costs and Reimbursement of Hospital Treatment of Venous Thromboembolism in PolandBochenek, T. / Nizankowski, R. et al. | 2012
-
PHS85 The Cost of Public Cancer Prevention in AlbertaJacobs, P. / Moffatt, J. et al. | 2012
-
PIH15 Prescribing Cost of Enzymes Over a Two-Year Period Using a Medical Insurance Claims DatabaseTruter, I. / Graz, C. J. et al. | 2012
-
PIH31 Intentional and Unintentional Non-Adherence Differ Across Prevalent Conditions in a Russian Patient PopulationGoren, A. / Isherwood, G. / Vietri, J. et al. | 2012
-
PIH50 Trends in Post-Marketing Commitments Related to Pregnancy and LactationAlbano, J. D. / Roberts, S. S. / Benter, U. / Whitehouse, J. et al. | 2012
-
PIH51 Review of All Products Authorized by the European Medicines Agency from 1995 to 2011 in Regard to Pediatric Investigation Plan ApplicationsMouchet, J. / Acquadro, C. / Emery, M. P. / Maier, W. et al. | 2012
-
PND12 Budget Impact Analysis of Routine Testing for Genetically Based Cardiopathies Associated With High Risk of Sudden Death in Spain: Preliminary ResultsFerná / ndez, I. / Garcí / a-Paví / a, P. / Ripoll, T. / Boldeanu, A. / Gracia, A. / Ramí / rez de Arellano, A. et al. | 2012
-
PND24 Methodological Considerations in Cost of Illness Studies on Alzheimer DiseaseCosta, N. / Derumeaux-Burel, H. / Rapp, T. / Garnault, V. / Ferlicoq, L. / Gillette, S. / Andrieu, S. / Vellas, B. / Lamure, M. / Grand, A. et al. | 2012
-
PND49 The Measurement of Quality of Life in Children With Cystic Fibrosis With Using Russian Version of Health Utility Index (HUI) QuestionnaireGorinova, Y. / Simonova, O. / Vinyarskaya, I. / Samsonova, M. / Chernikov, V. et al. | 2012
-
PND58 Effects of BG-12 on Quality of Life in Relapsing–Remitting Multiple Sclerosis: Findings From the Phase 3 Confirm StudyKita, M. / Fox, R. J. / Phillips, J. T. / Hutchinson, M. / Havrdova, E. / Sarda, S. P. / Kong, J. / Viglietta, V. / Sheikh, S. I. / Dawson, K. T. et al. | 2012
-
PRS5 Dual Bronchodilation With Indacaterol and Tiotropium in Combination Versus Triple Therapy, Fixed-Dose Combinations, and Monotherapy in COPD – a Network Meta-Analysis of FEV1Kraemer, M. / Ellis, A. / Baldwin, M. / Jansen, J. P. / Capkun-Niggli, G. / Cope, S. et al. | 2012
-
PRS11 The Short-Term Economic Impact of Three Childhood Preventive Health Programs in IsraelKeller, N. / Vo, P. / Sambrook, R. / Gooch, K. / Kendall, R. M. / Levy, A. R. et al. | 2012
-
PRS13 Variation of Cost of Chronic Obstructive Lung Disease in Adults in Germany: A Systematic ReviewKirsch, F. / Wenig, C. / Menn, P. / Leidl, R. et al. | 2012
-
PRS31 Cost-Effectiveness of an Intensive Intervention Program in the Control of Allergic Rhinitis Due to Ragweed Pollen in Quebec, CanadaLachaine, J. / Beauchemin, C. / Lapierre, M. E. / Masson, E. / Drapeau, J. B. / Groulx, J. et al. | 2012
-
PSS4 Acne and Lifestyle: Results of a Survey on a Representative Sample of the French PopulationWolkenstein, P. / Misery, L. / Amici, J. M. / Maghia, R. / Cazeau, C. / Voisard, J. J. / Taieb, C. et al. | 2012
-
PSS9 Cost of Blindness and Visual Impairment in SlovakiaPsenkova, M. / Mackovicova, S. / Ondrusova, M. / Szilagyiova, P. et al. | 2012
-
PSS12 Nepafenac for the Reduction in Risk of Post-Operative Macular Oedema Associated With Cataract Surgery in Diabetic Patients: A Cost-Effectiveness Estimation for ScotlandJackson, D. / Fisher, R. / Latif, F. et al. | 2012
-
CE3 Hyperbaric Oxygen Therapy for the Treatment Non-Neurological Soft Tissue Radiation Injuries- a Cost Effectiveness AnalysisCronin, P. / Hoggan, B. / Goodall, S. / Cameron, A. et al. | 2012
-
ME1 Comparison of the Measurement Properties Between the 5-Level EuroQoL Group's 5-Dimension (EQ-5D-5L) Questionnaire and the Functional Assessment of Cancer Therapy – Breast (FACT-B) in Asian Breast Cancer PatientsCheung, Y. B. / Lee, C. F. / Luo, N. / Ng, R. / Wong, N. S. / Yap, Y. S. / Lo, S. K. / Chia, J. / Yee, A. / Krishna, L. et al. | 2012
-
EX4 Recent Trends in Community Pharmacy Payment of National Health Insurance in South KoreaChoi, S. E. / Cheong, C. / Lee, H. / Kim, J. / Lim, E. A. et al. | 2012
-
PHP58 Direct Cost of Adverse Drug Reaction Treatment in Hospitalized Patients in Nakhon Pathom Hospital, ThailandKornkaew, J. / Auekusonsomboon, K. / Junklub, J. / Kongchat, J. / Maitreemit, P. / Sonchaem, T. et al. | 2012
-
PHP70 A 3-Year Follow-Up Study on National Health Insurance Reimbursements Among Atrial Fibrillation Patients With/Without Stroke in Taiwan: A Population-Based StudyLiu, C. Y. / Chen, H. C. / Chen, S. A. et al. | 2012
-
PHP82 The Characteristics of Clinical Trials in AsiaBrooks-Rooney, C. / Wong, G. K. / Hamerslag, L. / Costello, S. et al. | 2012
-
PHP105 Guideline Implementation in Long Term Asthma Management: An Audit Using a Medication Assesssment Tool in Selayang HospitalShaharuddin, S. / Che Hasan, M. H. / Hashim, R. et al. | 2012
-
PGI13 Vaccination Status Against Hepatitis B Among Healthy Population of Quetta, PakistanHaq, N. / Hassali, M. A. / Shafie, A. A. / Saleem, F. / Aljadhey, H. / Atif, M. et al. | 2012
-
PIH7 Immunization Providers' Cost and Vaccination Cost in IraqAl-Lela, O. Q. / Bahari, M. B. / Alabbassi, M. G. / Salih, M. / Basher, A. Y. et al. | 2012
-
PIH9 Assosiation Between Health Care Providers and Immunization Compliance in IraqAl-Lela, O. Q. / Bahari, M. B. / Alabbassi, M. G. / Salih, M. / Basher, A. Y. et al. | 2012
-
PIH11 A Survey Evaluating General Public Perceptions Towards Traditional Medicines Used for Aphrodisiac PurposeHassali, M. A. / Shafie, A. A. / Saleem, F. / Chua, G. N. / Masood, I. / Atif, M. / Haq, N. et al. | 2012
-
PRS2 Meta-Analysis of the Effects of Theophylline on Kidney Function in Neonates With Perinatal AsphyxiaPongmesa, T. / Poolsup, N. / Sirirattanapong, K. / Jitareerat, S. / Lertsesatid, Y. et al. | 2012
-
PRS10 Assessment of Knowledge Regarding Tuberculosis Among General Population in North East LibyaSolliman, M. M. / Hassali, M. A. / Al-Haddad, M. S. / Atif, M. / Shafie, A. / Saleem, F. / Aljadhey, H. / Haq, N. et al. | 2012
-
PRS13 Discriminating the Price of a Product Based on the Target Patient Segment by Launching Different Delivery Mechanisms: A Comparison of China, India and KoreaSeveri Bruni, D. / Storer, M. et al. | 2012
-
PSS5 New Formulation of Travoprost Reduces Dry Eye Occurrence and Costs in Glaucoma Patients: Model-Based Results for Hong KongTham, C. C. / Leung, C. K. / Li, F. C. / Gerlier, L. / Lamotte, M. / Caputo, J. / Tan, R. et al. | 2012
-
PRM2 Development and Validation of a Health Economic Model for Corticosteroid-Induced Osteoporosis in Postmenopausal Women With Rheumatoid Arthritis in JapanMoriwaki, K. / Noto, S. / Yanagisawa, S. / Ito, S. / Toujou, T. et al. | 2012
-
PRM10 Overview of the Prolabels Database Six Years After Its ImplementationPerrier, L. L. / Caron, M. / Murison, A. et al. | 2012
-
PRM17 Cost-Utility Analysis of Donepezil for the Treatment of Alzheimer's Disease in ThailandPermsuwan, U. / Niwatananun, W. / Pimkrai, A. et al. | 2012
-
PRM26 Comparison of Three Medication Adherence Measures in Patients Taking WarfarinWang, Y. / Kong, M. C. / Ko, Y. et al. | 2012
-
PCN19 Cost-Effectiveness Analysis of Temsirolimus in Patients With Poor Risk Renal-Cell CarcinomaKan, H. C. / Pwu, R. F. et al. | 2012
-
PCN33 Health Related Quality of Life in Post-Operative Breast Cancer PatientsJo, M. W. et al. | 2012
-
PDB3 Epidemiology, Patient Burden and Related Costs of Obesity in ChinaWojciechowski, P. / Metz, L. / Neoh, K. / Caban, A. / Gaweska, M. / Gomulka, A. / Plisko, R. / Wladysiuk, M. / Rys, P. et al. | 2012
-
PDB14 Prevalence of Hypertension and/or Obesity in Patients With Type 2 Diabetes Mellitus in Asia: A Systematic Literature ReviewColosia, A. D. / Palencia, R. / Khan, S. et al. | 2012
-
PMH10 Cost-Effectiveness of Antidepressant Based on Discrete Event Simulation Modeling in Treatment of Major Depressive Episodes: A Comparison of Agomelatine Versus Escitalopram-VenlafaxineSughondhabirom, A. / Chamchitchun, S. et al. | 2012
-
PMS16 Economic Evidence of Biologics in Rheumatoid Arthritis: A Systematic Review for Supporting Informed Decision of BNHILiao, C. H. / Chen, J. J. / Pwu, R. F. et al. | 2012
-
PND16 Qualitative Research Describing Patients' Perspectives of Successful Prophylactic Treatment With Botulinum Toxin Type a for Chronic MigraineGamble, V. / Vogel, N. / Guinan, G. / Ng, K. / Frost, M. et al. | 2012
-
PSY3 Assessing the Cost Effectiveness of Public Health Interventions to Prevent Obesity: A Systematic Review of the Effectiveness of 16 Obesity Prevention InterventionsPaech, D. / Coleman, K. / Mernagh, P. J. / Weston, A. R. et al. | 2012
-
PSY12 The Prevalence and Treatment Status of Hemophilia in India, Russia, Taiwan and Turkey: A Systematic Review and Meta AnalysisQu, Y. / Zhan, S. / Dong, P. et al. | 2012
-
DB1 Assessing the Relationship Between the Effect of Glycemic Control and Avoided Symptomatic Hypoglycemia on Quality of Life in the Management of Type 2 DiabetesFoos, V. / McEwan, P. / Lloyd, A. / Palmer, J. L. / Lamotte, M. / Grant, D. et al. | 2012
-
DB2 Economic Consequences of Severe Hypoglycaemia – Preliminary Findings from Five Central European CountriesNiewada, M. / Jakubczyk, M. / Czech, M. / Paweska, J. / Barszcz, E. et al. | 2012
-
DB3 How a Fear of Hypoglycemia Influences Health-Related Quality of Life in Type 2 Diabetes Mellitus Patients in Spain? Hipoqol-II StudyFont, B. / Lahoz, R. / Roldan, C. / Jó / dar, E. / lvarez, F. / vila, L. / Palomares, R. et al. | 2012
-
NI1 Three Years of Nice Scientific Advice: Comprehensive Analysis of Requests to the ProgrammePhillips, S. / Crowe, E. / Chivers, R. / Longson, C. et al. | 2012
-
QL1 EQ-5D-5L Valuation Project for the Spanish Population – A Descriptive Overview and Preliminary ResultsRamos-Goñ / i, J. / Errea, M. / Rivero-Arias, O. / Cabasé / s, J. M. / Pinto, J. L. et al. | 2012
-
PRM114 The Challenge of Translating the Picture Naming Subtest of the Repeatable Battery for the Assessment of Neuropsychological Status (RBANS)Rendu, E. / Harel, B. / Nomikos, A. / Caveney, A. / Acquadro, C. / Anfray, C. et al. | 2012
-
PRM117 Exploring Patient Perceptions of, and Preferences for, Pain Response ScalesQuadri, N. / Langel, K. / Muehlhausen, W. / O'Donohoe, P. / Wild, D. et al. | 2012
-
PRM135 Validity, Reliability and Responsiveness of the Spanish Minnesota Living With Heart Failure QuestionnaireBilbao, A. / Escobar, A. / Fernandez-Soto, M. L. / Gonzalez-Saenz de Tejada, M. / Lafuente, I. et al. | 2012
-
PRM143 Cluster Analysis and Principal Component Analysis to Assess the Variability of Data in Cost Evaluations: Methods and Applications in OncologyPerrier, L. / Buja, A. / Mastrangelo, G. / Sylvestre Baron, P. / Pauwels, P. / Ricardo Rossi, C. / Gilly, F. N. / Ducimetiè / re, F. / Favier, B. et al. | 2012
-
PRM153 Prioritizing Multiple Patient-Relevant Endpoints - a Methodological Comparison of Conjoint Analysis and Analytic Hierarchy Process Considering IQWiG‘s Efficiency Frontier ConceptNeidhardt, K. / Wasmuth, T. / Schmid, A. et al. | 2012
-
PRM156 How to Increase Patient Retention Rate During Their Participation in Longitudinal StudiesEl Kebir, S. / Gauchoux, R. / Nichols, S. E. et al. | 2012
-
PRM166 The Challenge of Assessing Health Technologies Early in the Development. Systematic Literature Review of Methods in UseMarkiewicz, K. / van Til, J. / IJzerman, M. J. et al. | 2012
-
PRM176 The Value of Further Research: The Added Value of Individual-Level DataSaramago, P. et al. | 2012
-
PDB44 Long-Term Evaluation of the Economic Impact of Reducing HbA1C by 1% in Type 2 Diabetes Patients in MexicoTodorova, L. / Gonzá / lez-Gá / lvez, G. / Pollock, R. F. et al. | 2012
-
PDB45 Cost-Effectiveness of Vildagliptin Compared to Generic Sulphonylureas Added on to Metformin From the Portuguese Societal PerspectiveCalado, F. / Gruenberger, J. B. / Silva-nunes, J. / Carvalho, D. et al. | 2012
-
PDB70 Characteristics of Long-Acting Somatostatin (SSA) Use in Acromegaly in the NetherlandsBezemer, I. D. / Penning, F. J. / Brulais, S. / Verduyn, C. S. / Herings, R. M. et al. | 2012
-
PDB72 Main Factors Associated to Costs of Type 2 Diabetes Mellitus (DM2) Care in Spain. A Systematic Review of the 2001-2011 LiteratureGonzales segura, D. / Paz, S. / Lizan, L. et al. | 2012
-
PSY1 Cardiovascular and Congenital Safety Evaluation of Antiobesity Agents, Including Topiramate: A Pharmacovigilance Analysis of the Adverse Event Reporting SystemAli, A. K. et al. | 2012
-
PSY32 Measuring the Level & Impact of Neuropathic Pain in the EUO'Hara, J. / Ruiz, L. / de Courcy, J. / Higgins, V. / Piercy, J. et al. | 2012
-
PHS4 Epidemiology and Control of Tuberculosis in OotyPatha, S. / Shireesha, G. / Krdas, S. / Thampy, S. et al. | 2012
-
PHS8 Use of Health Care Administrative Databases to Estimate Incidence of Foot Complications in Diabetes PatientsScalone, L. / Furneri, G. / Ciampichini, R. / Cortesi, P. A. / Fornari, C. / Madotto, F. / Chiodini, V. / Mantovani, L. G. / Cesana, G. et al. | 2012